US3668199A - 1,3-aminoalcohols - Google Patents
1,3-aminoalcohols Download PDFInfo
- Publication number
- US3668199A US3668199A US85718A US3668199DA US3668199A US 3668199 A US3668199 A US 3668199A US 85718 A US85718 A US 85718A US 3668199D A US3668199D A US 3668199DA US 3668199 A US3668199 A US 3668199A
- Authority
- US
- United States
- Prior art keywords
- give
- solution
- ether
- melting point
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 inclusive Chemical group 0.000 claims abstract description 198
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 42
- 239000001257 hydrogen Substances 0.000 claims abstract description 39
- 238000002844 melting Methods 0.000 claims description 115
- 230000008018 melting Effects 0.000 claims description 115
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 114
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 31
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical class Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 claims description 8
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 abstract description 36
- 239000002253 acid Substances 0.000 abstract description 28
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 16
- 150000003839 salts Chemical class 0.000 abstract description 14
- 125000000217 alkyl group Chemical group 0.000 abstract description 9
- 230000001882 diuretic effect Effects 0.000 abstract description 7
- 239000002934 diuretic Substances 0.000 abstract description 5
- 150000002367 halogens Chemical class 0.000 abstract description 5
- 239000003538 oral antidiabetic agent Substances 0.000 abstract description 5
- 229910052736 halogen Inorganic materials 0.000 abstract description 4
- 241000124008 Mammalia Species 0.000 abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 abstract description 3
- 230000002058 anti-hyperglycaemic effect Effects 0.000 abstract description 3
- 229940030606 diuretics Drugs 0.000 abstract description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 199
- 239000000243 solution Substances 0.000 description 139
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 129
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 110
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 110
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 88
- 239000000203 mixture Substances 0.000 description 77
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 67
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 62
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 60
- 150000002576 ketones Chemical class 0.000 description 52
- 238000004458 analytical method Methods 0.000 description 49
- 239000007787 solid Substances 0.000 description 45
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 44
- 239000003921 oil Substances 0.000 description 43
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 41
- 229910003446 platinum oxide Inorganic materials 0.000 description 41
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 37
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 37
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 36
- 239000000706 filtrate Substances 0.000 description 33
- VSSAZBXXNIABDN-UHFFFAOYSA-N cyclohexylmethanol Chemical compound OCC1CCCCC1 VSSAZBXXNIABDN-UHFFFAOYSA-N 0.000 description 32
- 239000000047 product Substances 0.000 description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- 239000000460 chlorine Substances 0.000 description 30
- 150000004699 copper complex Chemical class 0.000 description 28
- 239000000284 extract Substances 0.000 description 28
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 26
- 239000010410 layer Substances 0.000 description 25
- 239000011541 reaction mixture Substances 0.000 description 25
- 229920006395 saturated elastomer Polymers 0.000 description 25
- 239000012266 salt solution Substances 0.000 description 24
- 238000000746 purification Methods 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- 238000001953 recrystallisation Methods 0.000 description 22
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 20
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000000725 suspension Substances 0.000 description 18
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 17
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 16
- 238000010828 elution Methods 0.000 description 14
- 238000005984 hydrogenation reaction Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000001704 evaporation Methods 0.000 description 13
- 239000003208 petroleum Substances 0.000 description 13
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 11
- 150000007513 acids Chemical class 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 238000009835 boiling Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000005909 Kieselgur Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 8
- 239000000391 magnesium silicate Substances 0.000 description 8
- 229910052919 magnesium silicate Inorganic materials 0.000 description 8
- 235000019792 magnesium silicate Nutrition 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000012259 ether extract Substances 0.000 description 7
- 239000012458 free base Substances 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- 239000012299 nitrogen atmosphere Substances 0.000 description 7
- ISWILNMNCRJUMX-UHFFFAOYSA-N 2-(3,4,5-trimethoxybenzoyl)cyclohexan-1-one Chemical compound COC1=C(OC)C(OC)=CC(C(=O)C2C(CCCC2)=O)=C1 ISWILNMNCRJUMX-UHFFFAOYSA-N 0.000 description 6
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 235000019445 benzyl alcohol Nutrition 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000012280 lithium aluminium hydride Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 6
- SYMNQDJTFGCPSF-UHFFFAOYSA-N 2-(4-methoxybenzoyl)cyclohexan-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)C1C(=O)CCCC1 SYMNQDJTFGCPSF-UHFFFAOYSA-N 0.000 description 5
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 5
- 229930194542 Keto Natural products 0.000 description 5
- 150000001204 N-oxides Chemical class 0.000 description 5
- 150000001350 alkyl halides Chemical class 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 5
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- SVVSKFOWDXAYQR-UHFFFAOYSA-N 2-(2-methoxy-4-methylbenzoyl)cyclohexan-1-one Chemical compound COC1=C(C(=O)C2C(CCCC2)=O)C=CC(=C1)C SVVSKFOWDXAYQR-UHFFFAOYSA-N 0.000 description 4
- OHIMEGAKXAKACC-UHFFFAOYSA-N 2-(3,4,5-trimethoxybenzoyl)cyclopentan-1-one Chemical compound COC1=C(OC)C(OC)=CC(C(=O)C2C(CCC2)=O)=C1 OHIMEGAKXAKACC-UHFFFAOYSA-N 0.000 description 4
- RPPVKBCHQVEJNA-UHFFFAOYSA-N 2-(4-methoxybenzoyl)cyclopentan-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)C1C(=O)CCC1 RPPVKBCHQVEJNA-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 4
- BMCQFFXPECPDPS-UHFFFAOYSA-N cycloheptylmethanol Chemical compound OCC1CCCCCC1 BMCQFFXPECPDPS-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 150000003840 hydrochlorides Chemical class 0.000 description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- ZBJYJSBHVCATPO-UHFFFAOYSA-N 2-(2-methoxybenzoyl)cyclohexan-1-one Chemical compound COC1=C(C(=O)C2C(CCCC2)=O)C=CC=C1 ZBJYJSBHVCATPO-UHFFFAOYSA-N 0.000 description 3
- URJCLTJWGBGZCE-UHFFFAOYSA-N 2-(3,4,5-trimethoxybenzoyl)cycloheptan-1-one Chemical compound COC=1C=C(C(=O)C2C(CCCCC2)=O)C=C(C1OC)OC URJCLTJWGBGZCE-UHFFFAOYSA-N 0.000 description 3
- MNCFWYXCYZTXJU-UHFFFAOYSA-N 2-(4-chlorobenzoyl)cyclohexan-1-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C1C(=O)CCCC1 MNCFWYXCYZTXJU-UHFFFAOYSA-N 0.000 description 3
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical class ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 150000001649 bromium compounds Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000004913 cyclooctene Substances 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 125000000468 ketone group Chemical group 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 3
- NDNUANOUGZGEPO-UHFFFAOYSA-N (s)-2-propylpiperidine Chemical compound CCCC1CCCCN1 NDNUANOUGZGEPO-UHFFFAOYSA-N 0.000 description 2
- ZRSGZIMDIHBXIN-UHFFFAOYSA-N 1,3-benzodioxole-5-carbonyl chloride Chemical compound ClC(=O)C1=CC=C2OCOC2=C1 ZRSGZIMDIHBXIN-UHFFFAOYSA-N 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 2
- RYKVTWQXTLHHRO-UHFFFAOYSA-N 2-(2,3,4-trimethoxybenzoyl)cyclooctan-1-one Chemical compound COC1=C(C(=O)C2C(CCCCCC2)=O)C=CC(=C1OC)OC RYKVTWQXTLHHRO-UHFFFAOYSA-N 0.000 description 2
- NEDBCLWQCXIEJG-UHFFFAOYSA-N 2-(2-methylbenzoyl)cyclohexan-1-one Chemical compound CC1=CC=CC=C1C(=O)C1C(=O)CCCC1 NEDBCLWQCXIEJG-UHFFFAOYSA-N 0.000 description 2
- XFEUHSAOMVTOBR-UHFFFAOYSA-N 2-(4-bromobenzoyl)cyclooctan-1-one Chemical compound BrC1=CC=C(C(=O)C2C(CCCCCC2)=O)C=C1 XFEUHSAOMVTOBR-UHFFFAOYSA-N 0.000 description 2
- SNLTVULQJSFJER-UHFFFAOYSA-N 2-(4-ethoxybenzoyl)cyclohexan-1-one Chemical compound C(C)OC1=CC=C(C(=O)C2C(CCCC2)=O)C=C1 SNLTVULQJSFJER-UHFFFAOYSA-N 0.000 description 2
- MEOVIGGRRNHOAA-UHFFFAOYSA-N 2-(4-ethoxybenzoyl)cyclooctan-1-one Chemical compound C(C)OC1=CC=C(C(=O)C2C(CCCCCC2)=O)C=C1 MEOVIGGRRNHOAA-UHFFFAOYSA-N 0.000 description 2
- CXZGTFRVQYKCRH-UHFFFAOYSA-N 2-(4-methoxy-3,5-dimethylbenzoyl)cyclohexan-1-one Chemical compound CC=1C=C(C(=O)C2C(CCCC2)=O)C=C(C1OC)C CXZGTFRVQYKCRH-UHFFFAOYSA-N 0.000 description 2
- OADQEYNOCSVVRZ-UHFFFAOYSA-N 2-(4-methylbenzoyl)cyclohexan-1-one Chemical compound C1=CC(C)=CC=C1C(=O)C1C(=O)CCCC1 OADQEYNOCSVVRZ-UHFFFAOYSA-N 0.000 description 2
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 2
- ZXHHHBPLVWGPPX-UHFFFAOYSA-N 2-methoxy-4-methylbenzoyl chloride Chemical compound COC1=CC(C)=CC=C1C(Cl)=O ZXHHHBPLVWGPPX-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- ROLMZTIHUMKEAI-UHFFFAOYSA-N 4,5-difluoro-2-hydroxybenzonitrile Chemical compound OC1=CC(F)=C(F)C=C1C#N ROLMZTIHUMKEAI-UHFFFAOYSA-N 0.000 description 2
- XLWQUESMILVIPR-UHFFFAOYSA-N 4-ethoxybenzoyl chloride Chemical compound CCOC1=CC=C(C(Cl)=O)C=C1 XLWQUESMILVIPR-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- ICEKEZSKMGHZNT-UHFFFAOYSA-N 4-phenylmethoxybenzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1OCC1=CC=CC=C1 ICEKEZSKMGHZNT-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 241000508725 Elymus repens Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 235000008515 Setaria glauca Nutrition 0.000 description 2
- 235000001155 Setaria leucopila Nutrition 0.000 description 2
- 244000010062 Setaria pumila Species 0.000 description 2
- 240000003461 Setaria viridis Species 0.000 description 2
- 235000002248 Setaria viridis Nutrition 0.000 description 2
- 235000010086 Setaria viridis var. viridis Nutrition 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000002439 Sorghum halepense Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 2
- NRHDCQLCSOWVTF-UHFFFAOYSA-N azonane Chemical compound C1CCCCNCCC1 NRHDCQLCSOWVTF-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- ZHPBLHYKDKSZCQ-UHFFFAOYSA-N cyclooctylmethanol Chemical compound OCC1CCCCCCC1 ZHPBLHYKDKSZCQ-UHFFFAOYSA-N 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000002081 enamines Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 239000010948 rhodium Substances 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- WTDGGGGWFRZGDE-UHFFFAOYSA-N (1-piperidin-1-ylcyclohexyl)methanol Chemical compound C1CCCCN1C1(CO)CCCCC1 WTDGGGGWFRZGDE-UHFFFAOYSA-N 0.000 description 1
- DSGKWFGEUBCEIE-UHFFFAOYSA-N (2-carbonochloridoylphenyl) acetate Chemical compound CC(=O)OC1=CC=CC=C1C(Cl)=O DSGKWFGEUBCEIE-UHFFFAOYSA-N 0.000 description 1
- BTANRVKWQNVYAZ-SCSAIBSYSA-N (2R)-butan-2-ol Chemical compound CC[C@@H](C)O BTANRVKWQNVYAZ-SCSAIBSYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- CGEOYYBCLBIBLG-UHFFFAOYSA-N (4-carbonochloridoylphenyl) acetate Chemical compound CC(=O)OC1=CC=C(C(Cl)=O)C=C1 CGEOYYBCLBIBLG-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZNGWEEUXTBNKFR-UHFFFAOYSA-N 1,4-oxazepane Chemical compound C1CNCCOC1 ZNGWEEUXTBNKFR-UHFFFAOYSA-N 0.000 description 1
- KPVMGWQGPJULFL-UHFFFAOYSA-N 1-(cyclohexen-1-yl)piperidine Chemical compound C1CCCCN1C1=CCCCC1 KPVMGWQGPJULFL-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- YKSVXVKIYYQWBB-UHFFFAOYSA-N 1-butylpiperazine Chemical compound CCCCN1CCNCC1 YKSVXVKIYYQWBB-UHFFFAOYSA-N 0.000 description 1
- CUCJJMLDIUSNPU-UHFFFAOYSA-N 1-oxidopiperidin-1-ium Chemical compound [O-][NH+]1CCCCC1 CUCJJMLDIUSNPU-UHFFFAOYSA-N 0.000 description 1
- PHODFIDDEBEGCS-UHFFFAOYSA-N 2,2-dimethylpyrrolidine Chemical compound CC1(C)CCCN1 PHODFIDDEBEGCS-UHFFFAOYSA-N 0.000 description 1
- GAZNVVBKELWTBC-UHFFFAOYSA-N 2,3,4-trimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C(OC)=C1OC GAZNVVBKELWTBC-UHFFFAOYSA-N 0.000 description 1
- UJZQGFAOQWHZRE-UHFFFAOYSA-N 2,3,6-trimethylthiomorpholine Chemical compound CC1CNC(C)C(C)S1 UJZQGFAOQWHZRE-UHFFFAOYSA-N 0.000 description 1
- JUOGRBULLOEKKQ-UHFFFAOYSA-N 2,4-dimethylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C(C)=C1 JUOGRBULLOEKKQ-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- ZHFSZFRPVJZWER-UHFFFAOYSA-N 2-(2,4-dimethylbenzoyl)cyclohexan-1-one Chemical compound CC1=C(C(=O)C2C(CCCC2)=O)C=CC(=C1)C ZHFSZFRPVJZWER-UHFFFAOYSA-N 0.000 description 1
- ICQKVDTYLCXXND-UHFFFAOYSA-N 2-(2-hydroxybenzoyl)cyclohexan-1-one Chemical compound OC1=CC=CC=C1C(=O)C1C(=O)CCCC1 ICQKVDTYLCXXND-UHFFFAOYSA-N 0.000 description 1
- CMMUKVOTHQUTFW-UHFFFAOYSA-N 2-(2-methoxy-3-methylbenzoyl)cyclohexan-1-one Chemical compound COC1=C(C=CC=C1C)C(=O)C1CCCCC1=O CMMUKVOTHQUTFW-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FUZYGDWIRBOLRH-UHFFFAOYSA-N 2-(2-propylbenzoyl)cycloheptan-1-one Chemical compound C(CC)C1=C(C(=O)C2C(CCCCC2)=O)C=CC=C1 FUZYGDWIRBOLRH-UHFFFAOYSA-N 0.000 description 1
- JAJOWUBHRCVVSJ-UHFFFAOYSA-N 2-(3,4-dichlorobenzoyl)cyclooctan-1-one Chemical compound ClC=1C=C(C(=O)C2C(CCCCCC2)=O)C=CC1Cl JAJOWUBHRCVVSJ-UHFFFAOYSA-N 0.000 description 1
- TWHCGKKXEBOJGB-UHFFFAOYSA-N 2-(3,4-dipropylbenzoyl)cycloheptan-1-one Chemical compound C(CC)C=1C=C(C(=O)C2C(CCCCC2)=O)C=CC1CCC TWHCGKKXEBOJGB-UHFFFAOYSA-N 0.000 description 1
- HDWYWBQBLJGRND-UHFFFAOYSA-N 2-(3,5-diiodobenzoyl)cyclopentan-1-one Chemical compound IC=1C=C(C(=O)C2C(CCC2)=O)C=C(C1)I HDWYWBQBLJGRND-UHFFFAOYSA-N 0.000 description 1
- SNGRURZNKZPYAW-UHFFFAOYSA-N 2-(3-ethylbenzoyl)cyclooctan-1-one Chemical compound C(C)C=1C=C(C(=O)C2C(CCCCCC2)=O)C=CC1 SNGRURZNKZPYAW-UHFFFAOYSA-N 0.000 description 1
- AKXATQWGJAGEQA-UHFFFAOYSA-N 2-(3-fluorobenzoyl)cyclopentan-1-one Chemical compound FC=1C=C(C(=O)C2C(CCC2)=O)C=CC1 AKXATQWGJAGEQA-UHFFFAOYSA-N 0.000 description 1
- LTQGYKGEBLCIEO-UHFFFAOYSA-N 2-(3-pentylbenzoyl)cyclohexan-1-one Chemical compound C(CCCC)C=1C=C(C(=O)C2C(CCCC2)=O)C=CC1 LTQGYKGEBLCIEO-UHFFFAOYSA-N 0.000 description 1
- LRRJETUJJHSVTJ-UHFFFAOYSA-N 2-(4-carbonochloridoylphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(C(Cl)=O)C=C1 LRRJETUJJHSVTJ-UHFFFAOYSA-N 0.000 description 1
- NLRUEDCNJQEVPQ-UHFFFAOYSA-N 2-(4-chloro-2-methoxybenzoyl)cyclohexan-1-one Chemical compound COC1=C(C(=O)C2C(CCCC2)=O)C=CC(=C1)Cl NLRUEDCNJQEVPQ-UHFFFAOYSA-N 0.000 description 1
- NGNQOMJUXNRTNP-UHFFFAOYSA-N 2-(4-hexylbenzoyl)cyclopentan-1-one Chemical compound C(CCCCC)C1=CC=C(C(=O)C2C(CCC2)=O)C=C1 NGNQOMJUXNRTNP-UHFFFAOYSA-N 0.000 description 1
- BGTAUWPDOPOKRL-UHFFFAOYSA-N 2-(4-propoxybenzoyl)cyclooctan-1-one Chemical compound C(CC)OC1=CC=C(C(=O)C2C(CCCCCC2)=O)C=C1 BGTAUWPDOPOKRL-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JDEQLZXMMRACGW-UHFFFAOYSA-N 2-benzoylcycloheptan-1-one Chemical compound C=1C=CC=CC=1C(=O)C1CCCCCC1=O JDEQLZXMMRACGW-UHFFFAOYSA-N 0.000 description 1
- MMZLQZZIECUPHR-UHFFFAOYSA-N 2-benzoylcyclooctan-1-one Chemical compound C=1C=CC=CC=1C(=O)C1CCCCCCC1=O MMZLQZZIECUPHR-UHFFFAOYSA-N 0.000 description 1
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 description 1
- IUKSYUOJRHDWRR-UHFFFAOYSA-N 2-diazonio-4,6-dinitrophenolate Chemical compound [O-]C1=C([N+]#N)C=C([N+]([O-])=O)C=C1[N+]([O-])=O IUKSYUOJRHDWRR-UHFFFAOYSA-N 0.000 description 1
- WISZZHKHSREDOZ-UHFFFAOYSA-N 2-ethyl-5-methylmorpholine Chemical compound CCC1CNC(C)CO1 WISZZHKHSREDOZ-UHFFFAOYSA-N 0.000 description 1
- RGNFMQJLAOONTP-UHFFFAOYSA-N 2-ethylmorpholine Chemical compound CCC1CNCCO1 RGNFMQJLAOONTP-UHFFFAOYSA-N 0.000 description 1
- JFZLDRUSMYBXRI-UHFFFAOYSA-N 2-ethylpyrrolidine Chemical compound CCC1CCCN1 JFZLDRUSMYBXRI-UHFFFAOYSA-N 0.000 description 1
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 1
- GPZXFICWCMCQPF-UHFFFAOYSA-N 2-methylbenzoyl chloride Chemical compound CC1=CC=CC=C1C(Cl)=O GPZXFICWCMCQPF-UHFFFAOYSA-N 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical compound CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- UOADRGAJWNJVGC-UHFFFAOYSA-N 2-propan-2-ylpyrrolidine Chemical compound CC(C)C1CCCN1 UOADRGAJWNJVGC-UHFFFAOYSA-N 0.000 description 1
- HEYGLTRAXBZNAD-UHFFFAOYSA-N 3,3-dimethylmorpholine Chemical compound CC1(C)COCCN1 HEYGLTRAXBZNAD-UHFFFAOYSA-N 0.000 description 1
- VIOBGCWEHLRBEP-UHFFFAOYSA-N 3,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1OC VIOBGCWEHLRBEP-UHFFFAOYSA-N 0.000 description 1
- RDEHRKLSYJBKDV-UHFFFAOYSA-N 3,4-dimethylpyrrolidine Chemical compound CC1CNCC1C RDEHRKLSYJBKDV-UHFFFAOYSA-N 0.000 description 1
- LKHYLIILDFDDHW-UHFFFAOYSA-N 3,6-dimethylazepane Chemical compound CC1CCC(C)CNC1 LKHYLIILDFDDHW-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- KPUSZZFAYGWAHZ-UHFFFAOYSA-N 3-azabicyclo[2.2.2]octane Chemical compound C1CC2CCC1NC2 KPUSZZFAYGWAHZ-UHFFFAOYSA-N 0.000 description 1
- LICHZOBEUWVYSY-UHFFFAOYSA-N 3-azabicyclo[3.2.2]nonane Chemical compound C1CC2CCC1CNC2 LICHZOBEUWVYSY-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 description 1
- KZZPRWYOUNLBQK-UHFFFAOYSA-N 3-methylthiomorpholine Chemical compound CC1CSCCN1 KZZPRWYOUNLBQK-UHFFFAOYSA-N 0.000 description 1
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 1
- DENKGPBHLYFNGK-UHFFFAOYSA-N 4-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Br)C=C1 DENKGPBHLYFNGK-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- NVSLDNSTGOKOJF-UHFFFAOYSA-N 4-methoxy-3,5-dimethylbenzoyl chloride Chemical compound COC1=C(C)C=C(C(Cl)=O)C=C1C NVSLDNSTGOKOJF-UHFFFAOYSA-N 0.000 description 1
- NQUVCRCCRXRJCK-UHFFFAOYSA-N 4-methylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C=C1 NQUVCRCCRXRJCK-UHFFFAOYSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- WYMVIVUKHYHNBN-UHFFFAOYSA-N 4-prop-2-enoxybenzoyl chloride Chemical compound ClC(=O)C1=CC=C(OCC=C)C=C1 WYMVIVUKHYHNBN-UHFFFAOYSA-N 0.000 description 1
- YBPWIUSXQXYTSR-UHFFFAOYSA-N 4-propan-2-ylpiperidine Chemical compound CC(C)C1CCNCC1 YBPWIUSXQXYTSR-UHFFFAOYSA-N 0.000 description 1
- RQGBFVLTFYRYKB-UHFFFAOYSA-N 4-propylpiperidine Chemical compound CCCC1CCNCC1 RQGBFVLTFYRYKB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- 244000052363 Cynodon dactylon Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000551547 Dione <red algae> Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- SYFPXYGMQIWYKK-UHFFFAOYSA-N bis(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)C=2C=C(OC)C(OC)=C(OC)C=2)=C1 SYFPXYGMQIWYKK-UHFFFAOYSA-N 0.000 description 1
- YHKDMJOYMRUGBQ-UHFFFAOYSA-N bis[4-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC(C(F)(F)F)=CC=C1C(=O)C1=CC=C(C(F)(F)F)C=C1 YHKDMJOYMRUGBQ-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- LUEHNHVFDCZTGL-UHFFFAOYSA-N but-2-ynoic acid Chemical compound CC#CC(O)=O LUEHNHVFDCZTGL-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- XLOPRKKSAJMMEW-UHFFFAOYSA-N chrysanthemic acid Chemical compound CC(C)=CC1C(C(O)=O)C1(C)C XLOPRKKSAJMMEW-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- IXZARIFWLSNRHS-UHFFFAOYSA-N cycloheptyl-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC=1C=C(C=C(C1OC)OC)C(=O)C1CCCCCC1 IXZARIFWLSNRHS-UHFFFAOYSA-N 0.000 description 1
- PIDMMLPPJKGWBI-UHFFFAOYSA-N cyclohexylmethanol;hydrochloride Chemical compound Cl.OCC1CCCCC1 PIDMMLPPJKGWBI-UHFFFAOYSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- OGGLYJQVKQLORS-UHFFFAOYSA-N di(cyclohepten-1-yl)methanone Chemical compound O=C(C1=CCCCCC1)C1=CCCCCC1 OGGLYJQVKQLORS-UHFFFAOYSA-N 0.000 description 1
- MWJYEHMLQASLCI-UHFFFAOYSA-N di(cycloheptyl)methanone Chemical compound C1CCCCCC1C(=O)C1CCCCCC1 MWJYEHMLQASLCI-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DLLJVQNYBYOKGS-UHFFFAOYSA-N ethoxyethane;pentane Chemical compound CCCCC.CCOCC DLLJVQNYBYOKGS-UHFFFAOYSA-N 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical group C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- UCVODTZQZHMTPN-UHFFFAOYSA-N heptanoyl chloride Chemical compound CCCCCCC(Cl)=O UCVODTZQZHMTPN-UHFFFAOYSA-N 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 1
- 125000005473 octanoic acid group Chemical class 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 208000012175 toxemia of pregnancy Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- JUKPJGZUFHCZQI-UHFFFAOYSA-N undecanoyl chloride Chemical compound CCCCCCCCCCC(Cl)=O JUKPJGZUFHCZQI-UHFFFAOYSA-N 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IAHBIMWHYUOIOH-UHFFFAOYSA-N vanadium hydrochloride Chemical compound Cl.[V] IAHBIMWHYUOIOH-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
Definitions
- the invention further includes the compounds of formulae IV, [Va and IVb when in the form of the N-oxides, acid addition salts and quaternary alkyl ammonium halides in which the alkyl group has from 1 to 12 carbon atoms, inclusive, and the halogen can be chlorine, bromine and iodine. Also the acid addition salts of the compounds of formula III are embraced by this invention.
- heterocyclic amino radical having from 5 to 10 nuclear atoms examples include: pyrrolidino, 2-
- alkyl groups having from 1 to 6 carbon atoms are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, Z-methylbutyl, neopentyl, hexyl, 2- methylpentyl, 3-methylpentyl and the like.
- Alkyl groups for the quaternary ammonium halide salts include, in addition to the preceding alkyl groups, others such as heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the like.
- the halogen moiety in such salts includes iodine, bromine and chlorine.
- acyl groups Ac of hydrocarbon carboxylic acids are particularly the acyl groups of alkanoic acids of 2 to 12 carbon atoms, e.g., acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, hexanoyl, octanoyl, decanoyl, ,B-cyclopentylpropionyl, lauroyl; of benzoic and aralkanoic acids, e.g., benzoyl, phenylacetyl, 3-phenylpropionyl, toluoyl, ethylbenzoyl, propylbenzoyl; of alkenoic acids, e.g., acryloyl, crotonoyl, chrysanthemummonocarbonyl, cinnamoyl, hexenoyl; of alkynoic acids, e.g., prop
- R is understood fluorine, chlorine, bromine and iodine.
- amino function in formulae lV, lVa and IVb compounds furthermore pennits the transformation of these compounds, by neutralization with inorganic and organic acids, into acid addition salts such as the hydrochloride, hydrobromide, hydroiodide, sulfate, phosphate, perchlorate, pamoate, cyclohexanesulfamate, methanesulfonate, ethanesulfonate, ptoluenesulfonate, benzenesulfonate, tartrate, citrate, lactate, and the like.
- acid addition salts such as the hydrochloride, hydrobromide, hydroiodide, sulfate, phosphate, perchlorate, pamoate, cyclohexanesulfamate, methanesulfonate, ethanesulfonate, ptoluenesulfonate, benzenesulfonate, tartrate, citrate
- the compounds of formulae IV, IVa and lVb including the acid addition salts, the N-oxides, and the alkyl quaternary ammonium halides thereof, are compounds of significant diuretic activity. They may be administered to mammals and birds by both oral and parenteral routes in order to produce their pharmacological, that is, diuretic effects.
- the new compounds of formulae IV, IVa and IVb, as well as the acid addition salts, the N-oxides and the quaternary ammonium halide salts can be compounded into solid and liquid unit dosage forms such as tablets, capsules, powders, granules, syrups, elixirs and the like, containing the appropriate amounts for treatment.
- ⁇ For tablets, common pharmaceutically acceptable carriers are used such as starch, lactose, kaolin, dicalcium phosphate and the like.
- the compounds IV, IVa and lVb can also be given as powders, particularly in gelatin capsules with or without carriers such as methylcellulose, magnesium stearate, calcium stearate, talc and the like.
- these compounds may be dissolved or suspended in aqueous alcoholic vehicles with or without buffering agents and flavoring mixtures.
- compositions are administered to edematous animals for the treatment of conditions associated with excess electrolyte retention and excess fluid retention.
- the compositions are useful in treating the following conditions: edema associated with hepatic disease, edema and toxemia of pregnancy, hypertensive vascular disease, premenstrual fluid retention and congestive heart failure.
- Dosages between 0.5 and 30 mg./kg. of body weight are suitable to produce significantly increased diuresis.
- the ether cis-l-[2-(a,p-dimethoxybenzyl)cyclohexyl]-piperidine of melting point 83-85 C. produced at 5 mg. dosage level per kg. of body weight ofrats a 73 percent increase in diuresis, as determined by the procedure of Lipschitz et al., J. Pharmacol Exp. Therap. 79, 97, 1943.
- Examples 38, 39, 48, 54, 55, 97, 99, 100 and 136A have demonstrated significant anti-hyperglycemic activity in rats. They are useful as oral antidiabetic agents.
- the new compounds of formulae IV, IVa and IVb can be used in the form of their acid addition salts with inorganic or organic acids, for example, hydrochlorides, lactates, sulfates, tartrates, hydroiodides, hydrobromides, and the like.
- the fluosilicates of these compounds are useful moth-proofing agents according to U. S. Pat. Nos. 1,915,334 and 2,075,359.
- the thiocyanic acid addition salts of the same compounds can be condensed with formaldehyde to form resinous polymers which according to U. S. Pat. Nos. 2,425,320 and 2,606,155 are useful as pickling inhibitors.
- the trichloroacetic acid addition salts of the compounds of the same formulae IV, IVa and IV]; are useful as herbicides, for example, against Johnson grass, yellow foxtail, green foxtail, Bermuda grass and quack grass.
- a suitable composition of an electrocardiographic jelly thus prepared comprises:
- a 1,3- diketo compound (I) is reacted with heterocyclic amine in the presence of a acid catalyst and preferably under conditions in which the water produced in the condensation process is separated from the reaction mixture such as by employing an azeotropic separator together with the reflux condenser.
- solvent essentially water-free organic solvents are used such as benzene, toluene, xylene or the like.
- the alcohol IV is stirred with a solution of hydrogen chloride gas in a lower alkanol, e.g.,
- the product is obtained as a hydrochloride of the amino ether.
- the free base is obtained by treating the hydrochloride with a base, e.g., 20 percent aqueous sodium hydroxide, extracting the free base with a waterimmiscible solvent, e.g., ether, methylene chloride, chloroform and the like and evaporating the solvent.
- the alkyl quaternary ammonium halides of products of formula IV, IVa and IVb are produced by conventional methods such as heating to reflux a solution of the selected compound IV, IVa or IVb in the presence of methanol, ethanol, acetonitrile or the like with a selected alkyl halide such as an iodide or bromide or, less desirably, a chloride of methyl, ethyl, propyl, butyl, isobutyl, isopropyl, pentyl, hexyl, heptyl, octyl, decyl, undecyl, dodecyl or isomers of these alkyl compounds.
- a selected alkyl halide such as an iodide or bromide or, less desirably, a chloride of methyl, ethyl, propyl, butyl, isobutyl, isopropyl, pentyl,
- the thus-obtained copper complex (70 g.) was dissolved in 350 ml. of chloroform and decomposed with 670 ml. of percent aqueous hydrochloric acid to give 60 g. (yield 36 percent) of 2-(3,4,5-trimethoxybenzoyl)cyclopentanone having a melting point of 8186 C.
- a sample of this material was recrystallized from Skellysolve B hexanes to give 2-(3,4,5- trimethoxybenzoly)cyclopentanone of melting point 9295 C.
- EXAMPLE 8 EXAMPLE 9 2-(o-Methoxybenzoyl)cyclohexanone
- l-piperidino-l-cyclohexene was reacted with o-methoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(o-methoxybenzoyl)cyclohexanone of melting point 6568 C.
- EXAMPLE 1O 2-(o-I-Iydroxybenzoyl)cyclohexanone
- 1-piperidino-l-cyclohexene was reacted with o-acetoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(0-acetoxybenzoyl)cyclohexanone.
- the thus-obtained 2-(o-acetoxybenzoyl)cyclohexanone was subjected to alkaline hydrolysis, the mixture acidified and the 2-( o-hydroxybenzoyl)cyclohexanone recovered by extraction.
- EXAMPLE l6 Z-(p-Trifluoromethylbenzoyl)cyclohexanone
- l-piperidino-l-cyclohex ene was reacted with p-trifiuoromethylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-trifluoromcthylbenzoyl)cyclohexanone.
- EXAMPLE l8 2-(p-I-Iydroxybenzoyl)cyclohexanone
- l-piperidinol-cyclohexene was reacted with p-acetoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-acetoxybenzoyl)cyclohexanone.
- the thus-obtained 2-(p-acetoxybenzoyl)cyclohexanone was subjected to alkaline hydrolysis, the mixture acidified and the Z-(p-hydroxybenzoyl)cyclohexanone recovered by extraction.
- EXAMPLE 20 2-(p-Methylbenzoyl)cyclohexanone
- l-pyrrolidino-lcyclohexene was reacted with p-methylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (EXAMPLE 2), 2-(p-methylbenzoyl)cyclohexanone of melting point l08-l 10 C.
- EXAMPLE 23 2-(p-Allyloxybenzoyl)cyclohexanone
- l-piperidino-l-cyclohexene was reacted with p-allyloxybenzoyl chloride in chloroform solution to give after the copper complex purification procedure (Example 2), 2-(p-allyloxybenzoyl)cyclohexanone.
- EXAMPLE 30 to 10 nuclear atoms, inclusive, with a selected benzoyl chloride Representative starting materials, thus prepared, include: 2-(3,5-diiodobenzoyl) cyclopentanone; 2-(pfluorobenzoyl)cyclohexanone; 2-( 2-methoxy-4- chlorobenzoyl )cyclohexanone; 2-( 2-methoxy-3-methylbenzoyl) cyclohexanone; 2(2-methyl-4-trifluoromethylbenzoyl)cyclohexanone; 2-(3,4-dipropylbenzoyl)cycloheptanone; 2-(2,5-dich1orobenzoyl) cycloheptanone; 2-(3,4- dichlorobenzoyl )cyclooctanone; 2-( p-propoxybenzoyl)cyclooctanone; 2-( 2,5-dii0dobenzoyl )cycloheptanone; 2-(3
- EXAMPLE 3 2 a-( 3 ,4,5-Trimethoxyphenyl )-2-piperidinocyclohexanemethanol and its hydrochloride
- EXAMPLE 33 3 ,4,5-Trimethoxyphenyl 2-morpholino- 1 -cyclohcxenl -yl
- EXAMPLE 34 a-( 3 ,4 ,5-Trimethoxyphenyl )-2-morpholinocyc1ohexanemethanol and its hydrochloride
- a solution of 3,4,5-trimethoxyphenyl 2-morpholino-lcyclohexen-l-yl ketone [produced as in Example 33 from 8.75 g. of 2,-(3,4,5-trimethoxybenzoyl)cyclohexanone] in 100 ml. of ethanol was hydrogenated in the presence of 0.3 g. of platinum oxide catalyst at an initial hydrogen pressure of 52.5 pounds.
- Example 35 2-( 4-methyll -piperazinyl)- 1-
- Example 36 a-( 3 ,4,5-Trimethoxyphenyl )-2-(4-methyll -piperazinyl)cyclohexanemethanol dihydrochloride
- Example 37 p-Methoxyphenyl 2-piperidinol -cyclohexen- 1 -yl ketone
- 23.2 g. (0.1 mole) of 2- (p-methoxybenzoyl)cyclohexanone was heated with 25.5 g. (0.3 mole) of piperidine in 800 ml. of toluene in the presence of 0.67 g. of p-toluenesulfonic acid to give p-methoxyphenyl 2-piperidino-l-cyclohexen-1-y1 ketone.
- Example 38 Cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol
- a solution of p-methoxyphenyl 2-piperidino-l-cyclohexenl-yl ketone obtained from a synthesis of the same scale as shown in Example 37) in 300 m1.
- of ethanol was hydrogenated in the presence of l g. of platinum oxide under an initial hydrogen pressure of 51 pounds. Two molar equivalents of hydrogen were absorbed during a period of 2.5 hours. The mixture was filtered through Filtercei diatomaceous earth. The filtrate was then evaporated to dryness and the residue dissolved in 250 ml. of ether.
- the equatorial-equatorial positions of the vicinal substituents is the thermodynamically stable configuration and thus only one trans-p-methoxyphenyl 2-piperidinocyclohexyl ketone consisting of two optical forms, as for the cis compound, is obtained.
- the original ether layer above contained also l-(p-methoxy-benzoyl)-l-cyclohexene, a yellow oil boiling at l45-155 C.
- the resulting oil was extracted three times with ether.
- the ether extracts were combined, washed with water, the water discarded, then washed with four 25-ml. portions of percent aqueous acetic acid.
- the acidic extract was washed once with ether, and the ether discarded. It was then cooled in ice and basified with percent sodium hydroxide solution.
- the reaction mixture was then extracted three times with ether, the extracts combined, washed with water, then with saturated salt solution, dried over anhydrous sodium sulfate and evaporated to give 3 g. of an oil.
- the oily material was crystallized from 50 ml. of petroleum ether (boiling range 30-60 C.) to give 1.8 g. of cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol, melting point 78-80 C.
- cis alcohols A and B can also be produced from cis-pmethoxyphenyl Z-piperidinocyclohexyl ketone by reduction with lithium aluminum hydride.
- the resulting suspension was stirred for a period of 2 hours. It was then filtered and the solid washed with ether. The combined filtrate and washings were extracted with three portions of 30 ml. each of 10 percent aqueous acetic acid, and the combined acidic extracts were backwashed once with ether. The acidic extract was then basified with 15 percent aqueous sodium hydroxide and extracted three times with ether. The combined ether extracts were washed with water, saturated salt solution, and dried by passage through anhydrous sodium sulfate. The
- EXAMPLE 44 Trans-C-a-(p-methoxyphenyl)-2-piperidinocyc1ohexanemethanol 1n the manner given in Example 41, trans-p-methoxyphenyl Z-piperidinocyclohexyl ketone (3.01 g.; 0.01 mole) was hydrogenated in ethanol solution in the presence of 0.5 g. of platinum oxide catalyst at 53 pounds initialhydrogen pressure. The solution after 138 minutes of hydrogenation was filtered through Filtercel diatomaceous earth. The filtrate was evaporated giving 3 g. of a solid of melting point 14l-l45 C. This solid was crystallized from methanol to give 2.5 g.
- EXAMPLE 46 Trans-C- and trans-D-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol
- a solution of trans-p-methoxyphenyl 2-piperidinocyclohexyl ketone (23.9 g.; 0.0795 mole) in 575 ml. of ether was added to a solution of 24 g. of lithium aluminum hydride in 2,400 ml. of ether over a period of 30 minutes. The mixture was then stirred for about hours. It was thereupon decomposed successively with 24 ml. of water, 24 ml. of 15 percent aqueous sodium hydroxide and 72 ml. of water.
- Nuclear magnetic resonance spectrum (in CDCl;,) showed methoxy at 229 cps; broad band for benzylic hydrogen centered at 278.5 cps.
- Cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol A solution was prepared having 30.3 g. (0.1 mole) of cis-A- a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol in 200 ml. of trifluoroacetic acid, under cooling with ice. The mixture was then stirred at room temperature for 20 minutes, giving a greenish solution which was again cooled in ice. To this solution was added 150 g. of ice followed by 500 ml. of water and then 500 ml. of 20 percent aqueous sodium hydroxide.
- EXAMPLE 48 a-( 3,4,5-Trimethoxyphenyl )-2-( hexahydrol H-azepinl yl)cyclohexanemethanol hydrochloride OCH;
- the first crop of crystals amounted to 80.7 g.,of cis-A-a-(p-methoxyphenyl)-2- (hexahydrolH-azepinl -yl)cyclohexanemethanol hydrochloride of melting point of 230-23 1 C.
- a second crop of 20 g. was also collected. Further recrystallization did not change the melting point of the product.
- EXAMPLE 50 a(p-Trifluoromethylphenyl)-2-(hexahydro-lH-azepin-lyl)cyclohexanemethanol hydrochloride
- 0.1 mole of triethylamine and 0.1 mole of l-hexamethyleneimino-lcyclohexene was reacted irichloroform solution with 0.1 mole of p-trifluoromethylbenzoyl chloride.
- the resulting product was hydrogenated in 300 ml. of methanol in the presence of l g. of platinum oxide. Two molar equivalents of hydrogen were absorbed in 3.5 hours.
- the above compound is useful as a diuretic and oral antidiabetic agent.
- EXAMPLE 54 a-( 3 ,4-Dimethoxyphenyl )-2-( hexahydro- 1 H-azepin- 1 -yl) cyclohexanemethanol hydrochloride
- l-hexamethyleneiminol-cyclohexene was reacted with 3,4-dimethoxybenzoyl chloride (53.6 g.; 0.3 mole) in the presence of triethylamine.
- the resulting product was hydrogenated in the presence of platinum oxide and the mixture was worked up as in Example 53 giving 52.2 g.
- hydrochloride of cis-B-a-(p-methoxyphenyl)-2-(hexahydro-lI-I-azepin-l-yl)cyclohexanemethanol was prepared with 1.5 N ethereal hydrogen chloride. After two crystallizations from methanol-ether, colorless needles were obtained melting at 188-l 89 C.
- EXAMPLE 5 7 a-( 3 ,4,5-Trimethoxyphenyl )2-( 1-pyrolidinyl)cyclohexanemethanol and hydrochloride
- a mixture of 17.5 g. (0.06 mole) of 2-(3,4,5-trimethoxybenzoyl)cyclohexanone, 12.8 g. (0.18 mole) of pyrrolidine and 480 ml. of benzene was refluxed for 1.25 hours using an azeotropic separator; 1.5 ml. of water was collected. The mixture was evaporated to dryness to give a yellow oil. A small sample was crystallized twice from ether to give yellow prisms melting at 1l8120 C.
- EXAMPLE 58 3 ,4,5 -Trimethoxy-a-( Z-pipe ridinocyclopentyl)benzyl alcohol [a-( 3 ,4,5-trimethoxyphenyl)-2-piperidinocyclopentanemethanol] A. 3,4,5-Trimethoxyphenyl ketone.
- the above neutral layer contained a solid fraction of 8.78 g. which after recrystallization from Skellysolve B hexanes gave 6.8 of cyclopentyl 3,4,5trimethoxyphenyl ketone of melting point 46-47.5 C.
- EXAMPLE 60 p-Ethoxyphenyl 2-piperidino-1-cyclohexen-1-yl ketone
- Z-(p-ethoxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluene sulfonic acid to give p-ethoxyphenyl 21- piperidinol -cyclohexen- 1 -yl ketone.
- EXAMPLE 64 o-Methoxyphenyl Z-piperidino-l-cyclohexen-l-yl ketone
- 2-(o-methoxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give o-methoxyphenyl 2- piperidino- 1 -cyclohexen- 1 -y1 ketone.
- EXAMPLE 65 o-Hydroxyphenyl Z-piperidino-l-cyclohexen-l-yl ketone 1n the manner given in Example 31, Z-(o-hydroxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give o-hydroxyphenyl 2- piperidino- 1 -cyclohexen- 1 -yl ketone.
- EXAMPLE 65A p-Hydroxyphenyl 2-piperidino- 1 -cyclohexen- 1 -yl ketone
- 2-(p-hydroxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-hydroxyphenyl 2- piperidino-l-cyclohexen-1-yl ketone.
- EXAMPLE 67 EXAMPLE 68 p-Trifluoromethylphenyl ketone 2-piperidino- 1 -cyclohexenl -yl
- Z-(p-trifluoromethylbenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give ptrifluoromethylphenyl 2-piperidino-l-cyclohexcnl-yl ketone.
- EXAMPLE 69 p-Allyloxyphenyl Z-piperidino- 1 -cyclohexenl -yl ketone
- 2-(p-allyloxybenzoyl)- cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-allyloxyphenyl Z-piperidinol-cyclohexen-1-yl ketone.
- EXAMPLE 70 p-( Methylcarbamoyloxy)phenyl Z-piperidinol -cyclohexen- 1 -y1 ketone
- Z-[p-(methylcarbamoyloxy)-benzoyl]cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p- (methylcarbamoyloxy)phenyl 2-piperidinol -cyclohexenl -y] ketone.
- 2-(3,4-methylenedioxybenzoyl)cyclohexanone was reacted with hexamethylencimine in the presence of p-toluenesulfonic acid to give 3 ,4-methylenedioxyphenyl Z-(hexahydrol I-l-azepin- 1- yl)- l -cycIohexen-l-yl ketone.
- EXAMPLE 74 a-(p-Ethoxyphenyl)-2 hydrochloride
- p-ethoxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-ethoxyphenyD-Z- piperidinocyclohexanemethanol recovered as hydrochloride;
- EXAMPLE 75 a-(p-Benzyloxyphenyl)-2-pyrrolidinocyclohexanemethanol
- p-benzyloxyphenyl 2- pyrrolidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-benzyloXyphenyl)-2- pyrrolidinocyclohexanemethanol.
- EXAMPLE 76 Cis-A-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol
- p-benzyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give cis-A-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol of melting point 148.5-149.5 C.
- EXAMPLE 76A Cis-B-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol and hydrochloride thereof
- cis-A-a-(p-benzyloxyphenyl)-2 piperidinocyclohexanemethanol was converted by means of trifluoroacetic acid to cis-B-a-(p-benzyloxyphenyl)- 2-piperidinocyclohexanemethanol of melting point 129130 C.
- This base was treated with ethereal hydrogen chloride, to obtain cis-B-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride of melting point 238-240 C.
- EXAMPLE 77 a-[ p-( 2-l-lydroxyethoxy)phenyl]-2-piperidinocyclohexanemethanol hydrochloride
- p-(2-hydroxyethoxy)- phenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-[p- (2-hydroxyethoxy)-phenyl]-2-piperidinocyclohexanemethanol recovered as hydrochloride of melting point 196198 C.
- EXAMPLE 78 a-(o-Methoxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride
- o-methoxyphenyl 2- piperidino-l-cyclohexen-l-y1 ketone was hydrogenated in the presence of platinum oxide to give a-(o-methoxypheny1)-2- piperidinocyclohexanemethanol recovered as hydrochloride.
- EXAMPLE 79 a-(o-Hydroxyphenyl)-2-piperidinocyclohexanemethanol
- o-hydroxyphenyl 2- piperidinol-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(o-hydroxyphenyl)-2- piperidinocyclohexanemethanol of melting point l22-122.5 C.
- the above compound is useful as a diuretic.
- cis-A-a-(p-hydroxyphenyl)-2-piperidinocyclohexanemethanol was converted by means of trifluoroacetic acid to cis-B-a-(p-hydroxyphenyl)-2- cyclohexanemethanol of melting point l82l 83 C.
- EXAMPLE 8O a-(2-Methoxy-4-methylphenyl)-2-piperidinocyclohexanemethanol hydrochloride
- 2-methoxy-4- methylphenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(2- methoxy-4-methylphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride; melting point 25 l252 C.
- EXAMPLE 81 a-( 3 ,5-Dimethyl-4-methoxyphenyl )-2-piperidinocyclohexanemethanol hydrochloride
- 3,5-dimethyl-4-methoxyphenyl 2-piperidin0-1-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a- (3,5-dimethyl-4-meth0xyphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride.
- EXAMPLE 82 a-( p-Trifl uoromethylphenyl )-2-piperidinocyclohexanemethanol hydrochloride
- p-trifluoromethylphenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(ptrifluoromethylphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride.
- EXAMPLE 83 a-(p-Propoxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride
- p-allyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-propoxyphenyl)-2- piperidinocyclohexanemethanol recovered as hydrochloride.
- EXAMPLE 83A Cis-A-a-(p-allyloxyphenyl)-2piperidinocyclohexanemet hanol
- the above compound is useful as an oral antidiabetic agent.
- EXAMPLE 84 a-[p-(Methylcarbamoyloxy)phenyll-2-piperidinocyclohexanemethanol hydrochloride
- p-(methylcarbamoyloxy)-phenyl 2-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-[p- (methylcarbamoyloxy)-phenyl]-2-piperidinocyclohexanemethanol recovered as hydrochloride.
- EXAMPLE 85 EXAMPLE 86 a-( p-Chlorophenyl )-2-( 2-isopropylpyrrolidino )cyclohexanemethanol hydrochloride
- p-chlorophenyl 2-(2- isopropy1pyrrolidino)-l-cyclohexen-1-yl ketone was hydrogenated in the presence of platinum oxide to give oz-(pchlorophenyl)-2-(2-isopropylpyrrolidino)cyclohexanemet hanol recovered as hydrochloride.
- EXAMPLE 87 a-(p-I-Iydroxyphenyl)-2-octamethyleneiminocyclohexanemethanol hydrochloride
- p-hydroxyphenyl 2-0ctamethyleneiminol -cyclohexenl -yl ketone was hydrogenated in the presence of platinum oxide to give a-(phydroxyphenyl)-2-octamethyleneiminocyclohexanemethanol recovered as hydrochloride.
- hydrochlorides include: the hydrochlorides of a-(o-methylphenyl)-2-pyrrolidinocyclohexanemethanol; a- (p-methylphenyl)-2-pyrrolidinocyclohexanemethanol; a-(2- methoxy-4-methylphenyl)- 2-morpholinocyclohexanemethanol; a-(2-hydroxy-5-chlorophenyl)-2- homomorpholinocyclohexanemethanol; a-[p-(carboxymethoxy)phenyl]-2-(3,6-dimethylhexamethyleneimino)cyclohexanemethanol; a-( 3,4- methylenedioxyphenyl)-2-(Z-methylpiperidino)cyclohexanemethanol; a-(p-ethoxy
- EXAMPLE 88 Cis-p-benzyloxyphenyl Z-piperidinocyclohexyl ketone
- p-benzyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone dissolved in ethanol was hydrogenated in the presence of platinum oxide until one molar equivalent of hydrogen was consumed (42 minutes) to give cis-p-benzyloxyphenyl Z-piperidinocyclohexyl ketone of melting point 87.588.5 C.
- cis-ketones of formula III e.g., cis-3,4,5-trimethoxyphenyl 2-piperidinocyclohexyl ketone; cis-p-ethoxyphenyl Z-piperidinocyclohexyl ketone; cis-p-(2- hydroxyethoxy)-phenyl 2-piperidinocyclohexyl ketone; cis-ptrifluoromethylphenyl Z-piperidinocyclohexyl ketone; cis-pchlorophenyl 2-(2-isopropylpyrrolidino)cyclohexyl ketone; cis-3 ,4-methylenedioxyphenyl 2-( hexahydrol I-I-azepinl ketone; cis-2,3,4-trimethoxyphenyl 2- piperidinocycl
- cis-alcohols can be obtained by hydrogenating a compound of formula II or III in the presence of a catalyst such as platinum oxide, palladium or the like.
- Representative compounds thus obtained include: cis-a-(p-methylphenyl)-2-piperidinocyclohexanemethanol, melting point l02-l03 C., as hydrochloride melting point 25 l25 3 C.; cis-a-( p-methoxyphenyl )-2-( 4-methyll piperazinyl)cyclohexanemethanol, melting point 132133 C.; cis-a-( p-methoxyphenyl)-2-( 4-methylpiperidino)cyclohexanemethanol, melting point 93-94 C.; cis-a-(p-methoxyphenyl)-2-morpholinocyclohexanemethanol, melting point 1ll-112 C.; cis-a-(p-methoxyphenyl)-2
- Cis-B-l-[2-(a,p-dimethoxybenzyl)cyclohexyl]piperidine and hydrochloride thereof A A solution of cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol (3.0 g.; 0.01 mole) in 50 ml. of methanol was treated with a solution of 5 g. of hydrogen chloride in 50 ml. of methanol, and an additional 100 ml. of methanol was added. The solution was allowed to stand for 18 hours at about 25 C. and was then evaporated to dryness of 45 C. under reduced pressure. The oily residue was dissolved in 50 ml.
- the material was first eluted with eight portions of 250 ml. of a 5 percent ether-95 percent Skellysolve B hexanes solution. After evaporation of the combined eluates, 1.523 g. of solid material, melting between 82-84 C., was obtained. Further elution with two portions of 250 ml. of 25 percent ether-75 percent Skellysolve B hexanes, with two portions of 250 ml. each of 50 percent ether-50 percent Skellysolve B hexanes and with two portions of 250 ml. each of 75 percent ether-25 percent Skellysolve B hexanes gave a total of 0.204 g. of solid material after evaporation of the combined eluates.
- EXAMPLE 96 1-[ 2-( a-Ethoxy-p-methoxybenzyl)cyclohexyl]piperidine (cis-A isomer) and the hydrochloride thereof
- cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol (30.3 g.; 0.1 mole) in 250 ml. of ether was added during 45 minutes to a suspension of freshly prepared sodium amide (0.2 mole) in l l. of liquid ammonia. The mixture was stirred for 1 hour and then cooled in a Dry Ice-acetone bath.
- hydrochloride of cis-A-l-[2-(a-ethoxy-p-methoxybenzyl)-cyclohexyl]piperidine was prepared by treatment of an ethereal solution of the above oily base with ethereal hydrogen chloride. Two recrystallizations from ethanol gave colorless prisms of the hydrochloride of cis-A-l-[2-(a-ethoxy' p-methoxybenzyl)cyclohexy11piperidine of melting point 203-204.5 C.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Novel 1,3-aminoalcohol of the formula
WHEREIN N HAS THE VALUE OF 1 TO 4, INCLUSIVE, WHEREIN R'', R'''', and R'''''' are hydrogen, halogen, alkyl of 1 to 6 carbon atoms, inclusive, and alkoxy of 1 to 6 carbon atoms, inclusive, or CF3, are prepared. The new compounds of formula IV per se as well as in the form of acid addition salts have diuretic activity and some of them have antihyperglycemic activity. Compounds of formula IV are thus useful to provide diuretics in mammals and are also useful as oral antidiabetic agents.
WHEREIN N HAS THE VALUE OF 1 TO 4, INCLUSIVE, WHEREIN R'', R'''', and R'''''' are hydrogen, halogen, alkyl of 1 to 6 carbon atoms, inclusive, and alkoxy of 1 to 6 carbon atoms, inclusive, or CF3, are prepared. The new compounds of formula IV per se as well as in the form of acid addition salts have diuretic activity and some of them have antihyperglycemic activity. Compounds of formula IV are thus useful to provide diuretics in mammals and are also useful as oral antidiabetic agents.
Description
United States Patent" Primary Examiner-Alton D. Rollins Attorney-Hans L. Berneis and John Kekich Szmuszkovicz [451 June 6, 1972 [541 1,3-AMINQALCOHOLS I [72] Inventor: Jacob Szmuszkoviez, Kalamazoo, Mich. [57] ABSTRACT [73] Assignee: The Upjohn Company, Kalamazoo, Mich. la'ammoalcohol oflhe formula [22] Filed: Oct. 30, 1970 v (CH: R 4 [2!] Appl. No.: 85,718 E Related U.S. Applicatlon'Data l [62] Division of Ser. No. 556,892, June 13, 1966, Pat. No. N 3,558,599, which is a division of Ser. No. 786,385,
Dec. 23, 1968, Pat. No. 3,595,867.
, [52] U.S.Cl.. ..260/239 B, 260/239 BF, 424/244 Int. Cl. ..C07d wherein n has h value of l to 4 inclusive wherein R1 n 0 Search B and R; are y g g alkyl of l to 6 carbon atoms I inclusive, and alkoxy of l to 6 carbon atoms, inclusive, or CF:,, [56] Reerences cued are prepared. The new compounds-of formula W per se as UNITED STATES PATENTS well as in the form of acid addition salts have diuretic activity and some of them have antihyperglycemic activity. Com- 3,257,413 6/1966 ShOft ..260/294.7 und of f ula IV are thus useful to provide diuretics in mammals and are also useful as oral antidiabetic agents.
10 Claims, No Drawings 1,3-AMINOALCOHOLS CROSS-REFERENCES TO RELATED APPLICATIONS This application is a division of application Ser. No.
556,892 filed June 13, 1966, now US. Pat. No. 3,558,599 and 5 represents hexamethyleneimino, wherein R is an alkyl containing from 1 to 6 carbon atoms, inclusive, wherein R, R, R are selected from the group of substituents consisting of hydrogen, halogen, alkyl and alkoxy containing from 1 to 6 carbon atoms, inclusive, and--CF and wherein Ac is the acyl radical of a hydrocarbon carboxylic acid containing from 2 to 12 carbon atoms, inclusive.
The invention further includes the compounds of formulae IV, [Va and IVb when in the form of the N-oxides, acid addition salts and quaternary alkyl ammonium halides in which the alkyl group has from 1 to 12 carbon atoms, inclusive, and the halogen can be chlorine, bromine and iodine. Also the acid addition salts of the compounds of formula III are embraced by this invention.
Examples of the cycloalkyl radical illustratively represented by the formula are cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
Examples of the heterocyclic amino radical having from 5 to 10 nuclear atoms, include: pyrrolidino, 2-
methylpyrrolidino, 2-ethylpyrrolidino, 2,2-dimethylpyrrolidino, 3,4-dimethylpyrrolidino, 2-isopropylpyrrolidino, 2- sec.butylpyrrolidino, and like alkylpyrrolidino groups, morpholino, 2-ethylmorpholino, 2-ethyl-5-methylmorpholino,
LII
3,3-dimethylmorpholino, thiamorpholino, 3- methylthiamorpholino, 2,3,6-trimethylthiamorpholino, 4- methylpiperazino, 4-butylpiperazino, piperidino, 2-methylpiperidino, 3-methylpiperidino, 4-methylpiperidino, 4-propylpiperidino, 2-pr0pylpiperidino, 4-isopropylpiperidino, and like alkylpiperidino groups, hexarnethyleneimino, 2-methylhexamethyleneimino, 3,-dimethylhexamethyleneimino, homomorpholino, 1,2,3 ,4-tetrahydroquinolyl, heptamethyleneimino, octamethyleneimino, 3-azabicyclo[3,2,2 ]nonan-3-yl, 2-azabicyclo-[2,2,2]octan-2-yl, and the like.
Illustrative examples of alkyl groups having from 1 to 6 carbon atoms are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, Z-methylbutyl, neopentyl, hexyl, 2- methylpentyl, 3-methylpentyl and the like. Alkyl groups for the quaternary ammonium halide salts include, in addition to the preceding alkyl groups, others such as heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the like. The halogen moiety in such salts includes iodine, bromine and chlorine.
Illustrative examples of the acyl groups Ac of hydrocarbon carboxylic acids are particularly the acyl groups of alkanoic acids of 2 to 12 carbon atoms, e.g., acetyl, propionyl, butyryl, isobutyryl, valeryl, isovaleryl, hexanoyl, octanoyl, decanoyl, ,B-cyclopentylpropionyl, lauroyl; of benzoic and aralkanoic acids, e.g., benzoyl, phenylacetyl, 3-phenylpropionyl, toluoyl, ethylbenzoyl, propylbenzoyl; of alkenoic acids, e.g., acryloyl, crotonoyl, chrysanthemummonocarbonyl, cinnamoyl, hexenoyl; of alkynoic acids, e.g., propioloyl, 2- and 3-butynoyl and the like.
Under halogen substitutents for R, R or R is understood fluorine, chlorine, bromine and iodine.
The novel compounds III, IV, Wu and IVb exist in different steroisomeric forms such as geometric and optically active forms (e.g., compounds of formula III have at least two asymmetric carbon atoms, while the final products, IV, IVa and IVb, have at least three asymmetric carbon atoms) as well as in racemic mixtures. These optically active forms and racemic mixtures and geometric isomers are also encompassed by this invention.
The process of the present invention comprises: heating a diketo compound of formula I in which one of the radicals on the central carbonyl group is a 2-oxocycloalkyl group having from 5 to 8 carbon atoms, inclusive, and the other group is substituted or unsubstituted phenyl, with a heterocyclic amine having from 5 to 10 nuclear atoms, inclusive, in the presence of an acidic catalyst, e.g., p-toluenesulfonic acid, to give the unsaturated keto compound of formula II; hydrogenating the thus-obtained compound II in the presence of a hydrogenation catalyst, preferably a noble metal catalyst such as platinum oxide, rhodium, palladium or the like to add stepwise one and thereupon two molar equivalents of hydrogen, thus yielding respectively (with 1 molar equivalent of hydrogen) the keto compound III and (with 2 molar equivalents of hydrogen) the alcohol IV. The thus-obtained l,3-amino alcohols IV can be converted to alcohol derivatives such as ethers (IVa) with an alkyl halide (l to 6 carbon atoms) in the presence of a base, or with a lower alkanol (1 to 6 carbon atoms) in the presence of anhydrous hydrogen chloride, and to esters (IVb) with an acid anhydride or acid halide in a suitable organic solvent.
The amino function in formulae lV, lVa and IVb compounds furthermore pennits the transformation of these compounds, by neutralization with inorganic and organic acids, into acid addition salts such as the hydrochloride, hydrobromide, hydroiodide, sulfate, phosphate, perchlorate, pamoate, cyclohexanesulfamate, methanesulfonate, ethanesulfonate, ptoluenesulfonate, benzenesulfonate, tartrate, citrate, lactate, and the like. By treatment of the compounds of formulae IV, Na and IVb with peracids such as m-chloroperbenzoic acid, peracetic acid, perbenzoic acid, perphthalic acid, and the like, the corresponding N-oxide derivatives are obtained. By treatment of the compounds of formulae 1V, IVa and IVb with alkyl halides, the corresponding quaternary ammonium halide salts are obtained.
The compounds of formulae IV, IVa and lVb, including the acid addition salts, the N-oxides, and the alkyl quaternary ammonium halides thereof, are compounds of significant diuretic activity. They may be administered to mammals and birds by both oral and parenteral routes in order to produce their pharmacological, that is, diuretic effects. For oral administration, the new compounds of formulae IV, IVa and IVb, as well as the acid addition salts, the N-oxides and the quaternary ammonium halide salts, can be compounded into solid and liquid unit dosage forms such as tablets, capsules, powders, granules, syrups, elixirs and the like, containing the appropriate amounts for treatment. For tablets, common pharmaceutically acceptable carriers are used such as starch, lactose, kaolin, dicalcium phosphate and the like. The compounds IV, IVa and lVb can also be given as powders, particularly in gelatin capsules with or without carriers such as methylcellulose, magnesium stearate, calcium stearate, talc and the like. For fluid preparations, these compounds may be dissolved or suspended in aqueous alcoholic vehicles with or without buffering agents and flavoring mixtures.
The thus-obtained pharmaceutical formulations are administered to edematous animals for the treatment of conditions associated with excess electrolyte retention and excess fluid retention. For example, the compositions are useful in treating the following conditions: edema associated with hepatic disease, edema and toxemia of pregnancy, hypertensive vascular disease, premenstrual fluid retention and congestive heart failure. Dosages between 0.5 and 30 mg./kg. of body weight are suitable to produce significantly increased diuresis. For example, the ether cis-l-[2-(a,p-dimethoxybenzyl)cyclohexyl]-piperidine of melting point 83-85 C. produced at 5 mg. dosage level per kg. of body weight ofrats a 73 percent increase in diuresis, as determined by the procedure of Lipschitz et al., J. Pharmacol Exp. Therap. 79, 97, 1943.
The compounds of Examples 38, 39, 48, 54, 55, 97, 99, 100 and 136A have demonstrated significant anti-hyperglycemic activity in rats. They are useful as oral antidiabetic agents.
As noted above, the new compounds of formulae IV, IVa and IVb can be used in the form of their acid addition salts with inorganic or organic acids, for example, hydrochlorides, lactates, sulfates, tartrates, hydroiodides, hydrobromides, and the like. Moreover, the fluosilicates of these compounds are useful moth-proofing agents according to U. S. Pat. Nos. 1,915,334 and 2,075,359. The thiocyanic acid addition salts of the same compounds can be condensed with formaldehyde to form resinous polymers which according to U. S. Pat. Nos. 2,425,320 and 2,606,155 are useful as pickling inhibitors. The trichloroacetic acid addition salts of the compounds of the same formulae IV, IVa and IV]; are useful as herbicides, for example, against Johnson grass, yellow foxtail, green foxtail, Bermuda grass and quack grass.
The alkyl quaternary ammonium halides of the compounds of formulae IV, [Va and Nb, such as a-(3,4,5-trimethoxyphenyl)-2-(hexahydro-l-methyl-l-azepinium)cyclohexanemethanol iodide (Example 142), possess high wetting power and electroconductivity and are thus suitable to prepare electrocardiographic jellies.
A suitable composition of an electrocardiographic jelly thus prepared comprises:
Parts Glycerol 5 Starch l0 Quaternary ammonium salt 60 Water 100 The jelly is prepared by mixing the starch, glycerol and water and then adding the quaternary ammonium salt. The mixture is then allowed to stand for at least two days with occasional agitation to allow the formation ofa gel.
The starting materials of formula I are known in part from the art, e.g., Campbell et al., J. Am. Chem. Soc. 82, 2389, (1960); Linn et al., J. Am. Chem. Soc. 78, 6066 (1956);
Eistert et al., Ann. 650, 133 (1961). An elegant method by which the 1,3-diones of the type of formula I are synthesized consists of the reaction of a selected cycloalkanone with pyrrolidine or piperidine to give the corresponding enamine and to react the enamine with a selected substituted or unsubstituted benzoyl chloride [Campbell et al., J. Org. Chem. 28, 379 (1963)]. This particular method is shown repeatedly in the Examples in order to synthesize hitherto unknown 1,3- diones of the type of formula I.
In carrying out the process of the present invention a 1,3- diketo compound (I) is reacted with heterocyclic amine in the presence of a acid catalyst and preferably under conditions in which the water produced in the condensation process is separated from the reaction mixture such as by employing an azeotropic separator together with the reflux condenser. As solvent, essentially water-free organic solvents are used such as benzene, toluene, xylene or the like. The heterocyclic amines used include particularly pyrrolidine, 2-methylpyrrolidine, 2-ethylpyrrolidine, 2,2-dimethylpyrrolidine, 3,4- dimethylpyrrolidine, 2-isopropylpyrrolidine, 2-sec.butylpyrrolidine and other like alkylpyrrolidines; morpholine, 2-ethylmorpholine, 2-ethyl-5-methylmorpholine, 3,3-dimethylmorpholine, thiamorpholine, 3-methylthiamorpholine, 2,3,6- trimethylthiamorpholine and other like alkylmorpholines and alkylthiamorpholines; 4-methylpiperazine, 4-butylpiperazine and other like alkylpiperazines; piperidine, Z-methylpiperidine, 3-methylpiperidine, 4-methylpiperidine, 4-propylpiperidine, 2-propylpiperidine, 4-isopropylpiperidine and other like alkylpiperidines; hexamethyleneimine, Z-methylhexamethyleneimine, 3,6-dimethylhexamethyleneimine and other like alkylhexamethyleneimines; homomorpholine, l,2,3,4-tetrahydroquinoline, heptamethyleneimine, octamethyleneimine, 3-azabicyclo-[3.2.2]nonane, 2-azabicyclo[2.2.2]octane,'and the like.
The reaction is generally carried out at temperatures between 50-l50 C. but lower or higher temperatures are operative. Preferably, the reaction is carried out at the reflux temperature of the reaction mixture. The time for completion of the reaction is between 1 hour and 48 hours, but if low temperatures are used, longer reaction times are necessary. When the reaction is terminated, the product is isolated in conventional manner such as evaporating the reaction mixture to dryness.
The keto product of formula II is then hydrogenated in the presence of a catalyst, preferably platinum oxide, at a hydrogen pressure between 40 and 60 pounds per square inch. Larger or smaller pressures can be used, but pressure between 50-55 pounds at the beginning of the reaction are found to be most convenient. The reaction can be followed by the hydrogen absorption and can be allowed to go to completion, that is, to the point of addition of 2 molar equivalents of "hydrogen to give the alcohol of formula IV, or alternatively may be interrupted after the addition of 1 molar equivalent of hydrogen to give the keto compound of formula III. In cases where the addition of hydrogen is slow, additional amounts of catalyst may be added after an interval of several hours. Other catalysts that can be used in this reaction are palladium and rhodium, and these catalysts can be used with catalyst carriers such as charcoal, alumina and the like. After the hydrogenation is completed, the product is isolated by filtering the mix- ,ture to remove the catalyst and evaporating the solvent to obtain either the keto compound of formula III or the alcohol of formula IV. The thus-isolated products are purified by conventional means such as by crystallization and recrystallization, chromatography, or the like. If desired, the keto product of formula III can be hydrogenated again to give the alcohol of formula IV.
The conversion of the alcohol of formula IV to an ether of formula IVa is usually achieved by two methods: (I) reacting the alcohol of formula IV in liquid ammonia containing sodium amide or potassium amide at low temperature with the selected alkyl halide, or (2) reacting the alcohol of formula IV with a lower alkanol in the presence of hydrogen chloride. The starting temperature of the first method is usually the temperature of a Dry Ice-acetone bath, that is, approximately --70 C. and'is completed at about room temperature. In the preferred embodiment of this invention, the selected alcohol (IV), is dissolved in ether and is added to liquid ammonia containing sodium amide under continuous stirring. When this mixture reaches the Dry Ice-acetone bath temperature, a solution of thealkyl halide, preferably an alkyl iodide, is added over a few minutes time to allow cooling. When the calculated amount of alkyl halide is consumed, the reaction mixture in the flask is removed from the Dry Ice-acetone bath and allowed to warm to room temperature under continuous stirring. Instead of sodium amide, other strong basic compounds can be used such as potassium amide, lithium amide, and the like. Instead of liquid ammonia and alkali metal amides, other reaction systems can be used, e.g., butyl lithium in the presence of tetrahydrofuran and a temperature range of about 70 to 25C. After the reactionis terminated, the ether thus produced (lVa) is isolated by conventional procedures such as extraction, evaporation of solvents, formation of amine addition salts such as the hydrochloride, and using the differential water solubility of the hydrochloride and the like. For purification, recrystallization andchromatography are usually employed. v
In the second method, the alcohol IV is stirred with a solution of hydrogen chloride gas in a lower alkanol, e.g.,
methanol, ethanol, propanol, l-butanol, 2-butanol and the like, usually at room temperature. Lower or higher temperatures are operative, however. The product is obtained as a hydrochloride of the amino ether. The free base is obtained by treating the hydrochloride witha base, e.g., 20 percent aqueous sodium hydroxide, extracting the free base with a waterimmiscible solvent, e.g., ether, methylene chloride, chloroform and the like and evaporating the solvent.
Esters (IVb) of the alcohol of formula IV are usually ob- I tained in conventional manner, that is, treatment of the alcohol with an acid anhydride or acid halide, preferably in solution at room temperature. The solvents used in this reaction are methylene chloride, tetrahydrofuran, pyridine and the like. The anhydrides used in this reaction are usually of hydrocarbon carboxylic acids, e.g., of alkanoic acids such as acetic, propionic,-butyric, isobutyric, valeric, hexanoic, heptanoic, octanoic acids and the like; of benzoic and aralkanoic acids such as benzoic acid, salicyclic acid, toluic acid, phenylacetic acid, 3-phenylpropionic acid and the like; of cycloalkanoic acids, e.g., of cyclohexanecarboxylic acid and the like. The acid halides used in this reaction can be of alkanoic acids, particularly higher alkanoic acids having from 6 to 12 carbon atoms, such as hexanoyl chloride, heptanoyl chloride, octanoyl chloride, decanoyl chloride, undecanoyl chloride, lauroyl chloride or the acid bromides thereof, but the chlorides and bromides of lower alkanoic acids are also useful. The invention also encompasses the use of the anhydrides and acid chlorides and bromides of unsaturated acids such as cinnamic acid, acrylic acid, crotonic acid propiolic acid, 2-butynoic acid, chrysanthemummonocarboxylic acid and the like. After termination of the reaction, the product is isolated by conventional procedures such as extraction, chromatography, crystallization and the like.
Acid addition salts of the amino alcohols (IV), amino ethers (Na) and amino esters (IVb) are synthesized in the usual manner, that is, by directly reacting the acid with the free amine, preferably in an aqueous or anhydrous solvent such as water, ether, methanol, ethanol, ethyl acetate or the like. Evaporation of the solvent provides the desired acid addition salt.
N-oxidesof the compounds of formulae (IV), (Na) and (IVb) are obtained by reacting the compound at a tempera ture between 0-30 C., preferably at the start of the reaction at a temperature between 0l0 C., with a peracid such as peracetic, perpropionic, perbenzoic, 'perphtahlic, mchloroperbenzoic or other organic peracids in a solvent such as methanol, ethanol, ether or the like. Evaporation of the solvent provides the desired N-oxide of the products of formulae IV, IVa and IVb.
The alkyl quaternary ammonium halides of products of formula IV, IVa and IVb are produced by conventional methods such as heating to reflux a solution of the selected compound IV, IVa or IVb in the presence of methanol, ethanol, acetonitrile or the like with a selected alkyl halide such as an iodide or bromide or, less desirably, a chloride of methyl, ethyl, propyl, butyl, isobutyl, isopropyl, pentyl, hexyl, heptyl, octyl, decyl, undecyl, dodecyl or isomers of these alkyl compounds. After the reaction is terminated, the reaction mixture is evaporated to dryness to give the product which can be purified by recrystallization from organic solvents such as methanol, ethanol, ether, Skellysolve B hexanes, mixtures thereof and the like.
It is obvious from the configuration of products III, IV, [Va and IVb that these products can exist in more than one isomeric structure, since the compounds of formula III have at least two asymmetric centers and those of formula IV, Na and IVb have at least three asymmetric centers,- as noted above. It will be seen from the Examples that many of the reactions are either stereo-specific giving only one single product (racemic) or are stereo-selective, that is, giving one major component with smaller amounts of other components. Thus, the hydrogenation of the compound II to the ketone III with platinum oxide appears to give only one single form of the cisketone. Heating the thus-obtained cis-ketone with a base, for example, refluxing it with piperidine, produces a single transketone (III), which according to thermodynamic principles of stability has the substituents on the cycloalkane moiety in the equatorial position.
Further hydrogenation of a cis-k'etone of formula III with platinum oxide as catalyst produces one single cis-alcohol form (racemate A). Heating this cis-alcohol of formula IV with trifluoroacetic acid produces another formula IV cis-alcohol (racemate B).
Further hydrogenation. of a trans-ketone of formula III with platinum oxide as catalyst produces one single formula IV trans-alcohol (racemate C) which can be converted to the other formula IV trans-alcohol (racemate D) with trifluoroacetic acid. Reduction of a trans-ketone of formula III with lithium aluminum hydride produces the two above-mentioned trans-alcohols of formula IV; The racemates can be resolved by standard methods. The subsequent Examples further illustrate the stereo-isomeric considerations.
The following Examples are illustrative of the process and the products of the present invention, but are not to be construed as limiting.
EXAMPLE I 2-( 3,4,5 -Trimethoxybenzoyl )cyclohexanone A mixture of 147 g. (1.5 moles) of cyclohexanone and 213.3 g. (3 moles) of pyrrolidine was refluxed in 2,250 ml. of benzene in a flask equipped with an azeotropic separator. After the water formed during the reaction was collected, the solution was evaporated to dryness in vacuo and the resulting crude oil, consisting of l-pyrrolidino-l-cyclohexene, was used directly for the next step.
A solution of 3,4,5-trimethoxybenzoyl chloride (138.3 g.; 0.6 mole) in 240 ml. of chloroform was added during a period of 2 hours to a solution of the crude l-pyrrolidino-1-cyc1ohexene in 630 ml. of chloroform, under a nitrogen atmosphere, with continuous stirring while keeping the temperature between 5 to 10 C. After the solution was stirred overnight (about 18 hours) at room temperature (about 22 to 25 C.), there was added 900 ml. of 10 percent aqueous hydrochloric acid, and the resulting mixture was stirred at room temperature for 2 hours. The aqueous layer was extracted with two 150 ml. portions of chloroform, and the chloroform extracts were combined with the chloroform layer above. The combined extracts were washed with water, saturated aqueous sodium bicarbonate solution, water and saturated salt solution. The thus-obtained chloroform solution was dried by passing it through anhydrous sodium sulfate and the dry solution was evaporated to give a residue which was crystallized Analysis:
Calcd. for C I-1 Found: C, 65.48; H, 6.84
EXAMPLE 2 2-(3,4,5-Trimethoxybenzoyl)cyclopentanone A mixture of 126 g. (1.5 moles) of cyclopentanone and 213.3 g. (3 moles) of pyrrolidine was refluxed in 2,250 ml. of benzene in a flask equipped with an azeotropic separator. After the calculated amount of water, produced during the condensation, had been collected, the reaction mixture was evaporated to give as an oil l-pyrrolidino-l-cyclopentene.
A solution of 3,4,5-trimethoxybenzoyl chloride (138.3 g.; 0.6 mole) in chloroform was added to a chloroform solution of the oily l-pyrrolidino-l-cyclopentene over a period of 1 hour. The reaction mixture was thereupon worked up as in Example 1 to give a brown oil weighing 190 g. This oil was dissolved in 500 ml. of ethanol and the ethanol solution was added to a solution of 172 g. of cupric acetate monohydrate in 2,600 ml. of water. The mixture was stirred for one-half hour, cooled and filtered, providing a crude copper complex of 2-(3,4,5- trimethoxybenzoyl) cyclopentanone. This product was crystallized from methylene chloride to give 70 g. of the pure copper complex melting at 206208 C.
Analysis:
Calcd. for C H CuO C, 58.29; H, 5.54; Cu, 10.28 Found: C, 58.58; H, 5.81; Cu, 9.49
The thus-obtained copper complex (70 g.) was dissolved in 350 ml. of chloroform and decomposed with 670 ml. of percent aqueous hydrochloric acid to give 60 g. (yield 36 percent) of 2-(3,4,5-trimethoxybenzoyl)cyclopentanone having a melting point of 8186 C. A sample of this material was recrystallized from Skellysolve B hexanes to give 2-(3,4,5- trimethoxybenzoly)cyclopentanone of melting point 9295 C.
Analysis:
Calcd. for C.,H...
Found: C,
In a run twice the size of the above synthesis, a yield of 47 percent was obtained.
EXAMPLE 3 2-( 3 ,4,5-Trimethoxybenzoyl )cycloheptanone A mixture of 500 g. of cycloheptanone (4.5 moles), 785 g. of morpholine (9 moles), 900 ml. of toluene and 5 g. of ptoluenesulfonic acid was refluxed for 23 hours, collecting the water produced in the reaction with an azeotropic separator. Ninety-eight ml. of a lower phase was collected and discarded. The remaining mixture was then evaporated in vacuo to give an oil which was distilled. The fraction boiling between 1 l9-125 C. consisting essentially of 262.7 g. of lmorpholino-1-cycloheptene (32 percent yield).
In the manner given in Example 1, 3,4,5-trimethoxybenzoyl chloride (92.5 g.; 0.4 mole) was reacted with 181.37 g. (1 mole) of l-morpholino-l-cycloheptene. The crude product was crystallized from 500 ml. of methanol and gave a first crop of 26 g. of 2 -(3,4,5-trimethoxybenzoyl)cycloheptanone of melting point 99-100 C. After two more recrystallizations from methanol, the product had a melting point of lO7-108 C.
Analysis:
Calcd. for C H O Found: From the above methanolic filtrate another 48.3 g. of 2- (3,4,5-trimethoxybenzoyl)cycloheptanone was obtained as a second crop. The total yield was 61 percent.
EXAMPLE 4 2-(p-Methoxybenzoyl)cyclohexanone A solution of 167 g. (0.98 mole) of p-anisoyl chloride in 480 ml. of chloroform was added during a period of 1.5 hours to a solution of 371.7 g. (2.46 moles) of distilled l-pyrrolidino-lcyclohexene in 1260 ml. of chloroform. The temperature was kept between 5-10 C. by cooling with ice. After stirring for a period of about 20 hours at room temperature, the mixture was decomposed by addition of 1,800 ml. of 10 percent aqueous hydrochloric acid over a period of 20 minutes. The mixture was then stirred for 2 hours, allowed to settle, the organic layer was separated and the aqueous layer extracted twice with 250-ml. portions of chloroform. The original organic layer and the chloroform extracts were combined, washed with water, saturated salt solution, and then dried by passage through sodium sulfate and evaporated. The residue resulting from the above evaporation was a brown oil which was dissolved in l l. of ethanol and added to a solution of 344 g. of cupric acetate monohydrate in 5,200 ml. of water, preheated to 65 C. The mixture was stirred for 0.5 hour, cooled to room temperature and filtered. The obtained precipitate was washed with water and then with ether. It was then dissolved in 800 m1. of chloroform and added to a solution of 300 ml. of concentrated hydrochloric acid in 1,100 ml. of water. The mixture was stirred for 1 hour. The organic layer was separated, and the aqueous layer was extracted once with chloroform. The combined chloroform original layer and extract were washed with water, saturated salt solution, dried by passing through anhydrous sodium sulfate and evaporated, to give a solid which was crystallized from 7 l. of methanol, yielding 136.5 g. of 2-(p-methoxybenzoyl)cyclohexanone having a melting point of 1 15-128 C. A second crop of 26 g., melting point 116-127 C., was obtained from the mother liquor; the total yield was 71 percent. A recrystallized sample from methanol of 2-(p-methoxybenzoyl) cyclohexanone had a melting point of l 17-l22 C.
Analysis:
Calcd. for c,,n,,o,;
Found:
EXAMPLE 5 2-(p-Methoxybenzoyl)cyclopentanone In the manner given in Example 2, 204 g. (1.2 moles) of panisoyl chloride was reacted with l-pyrrolidino-l-cyclopentene prepared from 252 g. (3 moles) of cyclopentanone. The crude product was converted to the copper complex as in Example 4, the complex being crystallized from chloroformether to give g. of copper complex of 2-(p-methoxybenzoyl)cyclopentanone with a melting point of 252 C. (dec.). The copper complex was decomposed with hydrochloric acid to give 67 g. of an oil which was crystallized from methanol to give 13.9 g. of 2-(p-methoxybenzoyl)cyclopentanone of melting point 82-83 C. The filtrate from the first crystallization was evaporated to dryness and the residue crystallized from ether-Skellysolve B hexanes to give 30.1 g. of a second crop of Z-(p-methoxybenzoyl)cyclopentanone of melting point 7677 C. (total yield 17 percent). Two recrystallizations from methanol gave 2-(p-methoxybenzoyl)cyclopentanone having a melting point of 83-87 C.
Analysis:
Calcd. for C I-I O Found:
2-(p-Ethoxybenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohex- EXAMPLE l4 2-[p-(Methylcarbamoyloxy)benzoyllcyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with p-ethoxybenzoyl chloride in chloroform 5 ene was reacted with p-methylcarbamoyloxybenzoyl chloride solution to give, after the copper complex purification procedure (Example 2), 2-(p-ethoxybenzoyl)cyclohexanone.
EXAMPLE 7 2-(p-Benzyloxybenzoyl)cyclohexanone In the manner given in Example 2, l-pyrrolidino-lcyclohexene 'wasreacted with p-benzyloxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-benzyloxybenzoyl)cyclohexanone of melting point I ll-l l 1.5 C.
EXAMPLE 8 EXAMPLE 9 2-(o-Methoxybenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with o-methoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(o-methoxybenzoyl)cyclohexanone of melting point 6568 C.
EXAMPLE 1O 2-(o-I-Iydroxybenzoyl)cyclohexanone In the manner given in Example 2, 1-piperidino-l-cyclohexene was reacted with o-acetoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(0-acetoxybenzoyl)cyclohexanone. The thus-obtained 2-(o-acetoxybenzoyl)cyclohexanone was subjected to alkaline hydrolysis, the mixture acidified and the 2-( o-hydroxybenzoyl)cyclohexanone recovered by extraction.
EXAMPLE ll 2-( 2-Methoxy-4-methylbenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with 2-methoxy-4-methylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-( 2-methoxy-4-methylbenzoyl)cyclohexanone.
EXAMPLE l2 2-(p-Methoxybenzoyl)-4,4-dirnethylcyclohexanone In the manner given in Example 2, l-piperidino4,4- dimethyl-l-cyclohexene was reacted with p-methoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-methoxybenzoyl)-4,4-dimethylcyclohexanone.
EXAMPLE l3 2-(3,5-Dimethyl-4-methoxybenzoyl)cyclohexanone In the manner given in Example 2, l-pyrrolidino-lcyclohexene was reacted with 3,5-dimethyl-4-methoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(3,5' dimethyl-4-methoxybenzoyl)cyclohexanone of melting point l-l26 C.
in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-[p-(methylcarbamoyloxy)benzoyl]cyclohexanone.
EXAMPLE l5 2-( 3,4-Methylenedioxybenzoyl )cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with 3,4methylenedioxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(3,4-methylenedioxybenzoyl)cyclohexanone.
EXAMPLE l6 Z-(p-Trifluoromethylbenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohex ene was reacted with p-trifiuoromethylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-trifluoromcthylbenzoyl)cyclohexanone.
EXAMPLE l7 2-( p-Chlorobenzoyl)cyclohexanone In the manner given in Example 2, l-piperidinol-cyclohexene was reacted with p-chlorobenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-chlorobenzoyl)cyclohexanone.
EXAMPLE l8 2-(p-I-Iydroxybenzoyl)cyclohexanone In the manner given in Example 2, l-piperidinol-cyclohexene was reacted with p-acetoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-acetoxybenzoyl)cyclohexanone. The thus-obtained 2-(p-acetoxybenzoyl)cyclohexanone was subjected to alkaline hydrolysis, the mixture acidified and the Z-(p-hydroxybenzoyl)cyclohexanone recovered by extraction.
EXAMPLE l9 2-(o-Methylbenzoyl)cyclohexanone In the manner given in Example,2, l-piperidino-l-cyclohexene was reacted with o-methylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(o-methylbenzoyl)cyclohexanone.
EXAMPLE 20 2-(p-Methylbenzoyl)cyclohexanone In the manner given in Example 2, l-pyrrolidino-lcyclohexene was reacted with p-methylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (EXAMPLE 2), 2-(p-methylbenzoyl)cyclohexanone of melting point l08-l 10 C.
EXAMPLE 21 2-( 2,4-Dimethylbenzoyl )cyclohexanone In the manner given in Example 2, l-pyrrolidino-lcyclohexene was reacted with 2,4-dimethylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(2,4dimethylbenzoyl)c yclohexanone of melting point 5 l-52.5 C.
EXAMPLE 22 2-( 2-Methoxy'4-methylbenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with 2-methoxy-4-methylbenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(2-methoxy-4-methylbenzoyl)cyclohexanone.
EXAMPLE 23 EXAMPLE 24 2-(p-Allyloxybenzoyl)cyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with p-allyloxybenzoyl chloride in chloroform solution to give after the copper complex purification procedure (Example 2), 2-(p-allyloxybenzoyl)cyclohexanone.
EXAMPLE 25 2-[p-(Carboxymethoxy)benzoyljcyclohexanone In the manner given in Example 2, l-piperidino-l-cyclohexene was reacted with p-(carboxymethoxy)benzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-[p-(carboxymethoxy)benzoyl]cyclohexanone.
EXAMPLE 26 2-(p-Benzyloxybenzoyl)cycloheptanone In the manner given in Example 2, l-pyrrolidino-lcycloheptene was reacted with p-benzyloxybenzoyl chloride in chloroform solution to give after the copper complex purification procedure (Example 2), 2-(p-benzyloxybenzoyl)cycloheptanone.
EXAMPLE 27 2-(p-Ethoxybenzoyl)cyclooctanone In the manner given in Example 2, l-morpholino-l-cyclooctene was reacted with p-ethoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-ethoxybenzoyl)cyclooctanone.
EXAMPLE 28 2-(2,3,4-Trimethoxybenzoyl)cyclooctanone In the manner given in Example 2, l-piperidino-I-cyclooctene was reacted with 2,3,4-trimethoxybenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(2,3,4-trimethoxybenzoyl)cyclooctanone.
EXAMPLE 29 2-(p-Bromobenzoyl)cyclooctanone In the manner given in Example 2, l-piperidino-l-cyclooctene was reacted with p-bromobenzoyl chloride in chloroform solution to give, after the copper complex purification procedure (Example 2), 2-(p-bromobenzoyl)cyclooctanone.
EXAMPLE 30 to 10 nuclear atoms, inclusive, with a selected benzoyl chloride. Representative starting materials, thus prepared, include: 2-(3,5-diiodobenzoyl) cyclopentanone; 2-(pfluorobenzoyl)cyclohexanone; 2-( 2-methoxy-4- chlorobenzoyl )cyclohexanone; 2-( 2-methoxy-3-methylbenzoyl) cyclohexanone; 2(2-methyl-4-trifluoromethylbenzoyl)cyclohexanone; 2-(3,4-dipropylbenzoyl)cycloheptanone; 2-(2,5-dich1orobenzoyl) cycloheptanone; 2-(3,4- dichlorobenzoyl )cyclooctanone; 2-( p-propoxybenzoyl)cyclooctanone; 2-( 2,5-dii0dobenzoyl )cycloheptanone; 2-(3-fluorobenzoyl)cyclopentanone; 2-(pbromobenzoyl)cyclopentanone; 2-(p-hexylbenzoyl)cyclopentanone; 2-( 3-pentylbenzoyl )cyclohexanone; 2-( 2-bu tylbenzoyl)cyclohexanone; 2-( 2-propylbenzoyl)cycloheptanone; 2-( 3-ethylbenzoyl )cyclooctanone; 2-( 2-methoxy-5- bromo)cyclopentanone; 2benzoylcyclooctanone; 2-benzoylcycloheptanone; and the like.
EXAMPLE 31 3,4,5-Trimethoxyphenyl 2-piperidinol -cyclohexenl-yl ketone A mixture consisting of 35 g. (0.12 mole) of 2-(3,4,5- trimethoxybenzoyl)cyclohexanone, 30.6 g. (0.36 mole) of piperidine, 960 ml. of toluene, and 0.8 g. of p-toluenesulfonic acid was refluxed for 23 hours under nitrogen using an azeotropic separator (during this time 1.8 ml. of water was collected). The mixture was thereupon evaporated to dryness to give partially crystalline 3,4,5-trimethoxyphenyl 2- piperidino- 1 -cyclohexen- 1 -yl ketone.
EXAMPLE 3 2 a-( 3 ,4,5-Trimethoxyphenyl )-2-piperidinocyclohexanemethanol and its hydrochloride A solution of 3,4,5-trimethoxyphenyl 2-piperidino-1- cyclohexen-l-yl ketone prepared from 35 g. of 2-(3,4,5- trimethoxybenzoyl)cyclohexanone and 30.6 g. of piperidine, as in Example 31] in 300 ml. of ethanol was hydrogenated in the presence of 1.2 g. of platinum oxide at an initial pressure of 50.1 pounds of hydrogen. Two molar equivalents of hydrogen were taken up during 3.5 hours. The mixture was filtered through a filter aid and evaporated to dryness. The oily residue was dissolved in 400 ml. of ether and 400 ml. of 10 percent aqueous hydrochloric acid was added. The thus-obtained reaction mixture was stirred for 0.5 hour. A suspension was obtained which was filtered, yielding an original filtrate" and a solid which was washed with ether. The solid was twice recrystallized from methanol to give 14.7 g. of a-(3,4,5- trimethoxyphenyl-Z-piperidinocyclohexanemethanol hydrochloride of melting point 265-266 C. An analytical sample, prepared by additional recrystallization from methanol had a melting point of 266267 C. Ultraviolet: sh 228 (8,100); sh 232; A max. 269 (825); sh 278 (612).
Analysis:
Calcd. for C H NOJ'ICI:
C, 63.06; H, 8.57; Cl, 8.87; N, 3.50 Found: C, 62.99; H, 8.24; Cl, 8.66; N, 3.46
The above original filtrate was separated into layers, the aqueous layer was extracted with ether and then basified and extracted with methylene chloride. The extract was washed with water and saturated salt solution, then dried by pouring through anhydrous sodium sulfate and the water-free solution was evaporated to give 5.0 g. of an oil. The oil was converted to the hydrochloride with ethereal hydrogen chloride to give a second crop of 0.7 g. of a-(3,4,5-trimethoxyphenyl)-2- piperidinocyclohexanemethanol hydrochloride (total yield 32 percent; 15.4 g.).
The ether layer, after washing, drying and evaporation, gave 6.1 g. of an oil which was redissolved in ether and allowed to crystallize, yielding 0.5 g. of a-(3,4,5-trimethoxyphenyl)-2- hydroxycyclohexanemethanol of melting point -l31 C. (after additional recrystallization from ether).
Analysis:
Calcd. for c,,r-r,,o,=
Found: v c, 64.69; H, 8.29
EXAMPLE 33 3 ,4,5-Trimethoxyphenyl 2-morpholino- 1 -cyclohcxenl -yl EXAMPLE 34 a-( 3 ,4 ,5-Trimethoxyphenyl )-2-morpholinocyc1ohexanemethanol and its hydrochloride A solution of 3,4,5-trimethoxyphenyl 2-morpholino-lcyclohexen-l-yl ketone [produced as in Example 33 from 8.75 g. of 2,-(3,4,5-trimethoxybenzoyl)cyclohexanone] in 100 ml. of ethanol was hydrogenated in the presence of 0.3 g. of platinum oxide catalyst at an initial hydrogen pressure of 52.5 pounds. Two molar equivalents of hydrogen were taken up during a period of 6 ours. The mixture was filtered through diatomaceous earth (Filtercel) and evaporated to dryness. The resulting oil was dissolved in 100 ml. of 10 percent aqueous hydrochloric acid, 100 ml. of ether was added and the mixture was stirred for one-half hour. The aqueous layer was extracted twice with two 50-ml. portions of ether. The ether extracts were combined, washed with water, then with saturated salt solution, and finally dried by passage through anhydrous sodium sulfate. The thus-obtained solution was evaporated to give 2.3 g. of an oily material which after crystallization from ether gave 1 g. of 1-(3,4,5-trimethoxybenzoyl)-l-cyclohexene of melting point 73 74 C.
The above aqueous layer was cooled in ice, basified by adding sodium hydroxide solution and extracted with methylene chloride (three portions of 100 ml.). The extracts were combined, washed with water and saturated salt solution, and dried by passing through anhydrous sodium sulfate. The thusobtained solution was concentrated to give 7.89 g. of an oily material which was converted to the hydrochloride by adding a solution of hydrogen chloride in ether. The solid thus obtained was recrystallized frommethanol-ether to give 5 g. (42 percent yield) of a-(3,4,5-trimethoxyphenyl)-2-morpholinocyclohexanemethanol hydrochloride of melting point 20520 6 C.
Ultraviolet: sh 288 (8,150); sh 236 (6,350); A max. 269 (788); sh 278 (555).
Analysis:
Calcd. for C ,,H ,NO -HCl:
C, 59.76; H, 8.03; Cl, 8.82; N, 3.49 Found: C, 59.81; H, 8.52; l, 8.52; N, 3.57
Example 35 2-( 4-methyll -piperazinyl)- 1- Example 36 a-( 3 ,4,5-Trimethoxyphenyl )-2-(4-methyll -piperazinyl)cyclohexanemethanol dihydrochloride A solution of 3,4,5-trimethoxyphenyl 2-(4-methyl-lpiperazinyl)-l-cyclohexenl-yl ketone, prepared from 8.75 g. of 2-(3,4,5-trimethoxybenzoyl)cyclohexanone as in Example 35, was dissolved in ml. of methanol and then hydrogenated in the presence of 0.3 g. of platinum oxide at an initial pressure of 54 pounds. After 6.5 hours, the hydrogenation became sluggish, therefore, 0.03 mole of acetic acid and 0.3 g. of platinum oxide were added. After another period of 3 hours a total of 2 molar equivalents of hydrogen was absorbed. The mixture was filtered through diatomaceous earth (Filtercel) and evaporated to dryness. The resulting oil was dissolved in 100 ml. of 10 percent aqueous hydrochloric acid and 100 ml. of ether and the solution was stirred for 0.5 hour. The aqueous layer was extracted with three SO-ml. portions of methylene chloride. The extracts were discarded. The aqueous solution was then basified and extracted with four portions of 50 ml. each of methylene chloride. The methylene chloride extracts were combined, washed with water and with saturated salt solution, dried by passing through anhydrous sodium sulfate and evaporated to give 5.9 g. of oil. This oil was dissolved in ether and then acidified with 35 ml. of 2N ethereal hydrogen chloride. The resulting solid was recrystallized from methanol, yielding 4.4 g. (31 percent yield) of a-(3,4,5- trimethoxyphenyl )-2-(4-methyll -piperazinyl )cyclohexanemethanol dihydrochloride hemimethanol solvate of melting point 232-233 C.
Ultraviolet: sh 228 (8,400); sh 234.5 (6,850); A max. 270.5 (980); sh 278 (915).
Analysis:
Calcd. for C ,l-l N,O;2HCl' /& cruou;
C, 55.24; H, 8.19; Cl, 15.17; Found: C, 54.90; H, 8.05; CI, 15.30;
Example 37 p-Methoxyphenyl 2-piperidinol -cyclohexen- 1 -yl ketone In the manner given in Example 31, 23.2 g. (0.1 mole) of 2- (p-methoxybenzoyl)cyclohexanone was heated with 25.5 g. (0.3 mole) of piperidine in 800 ml. of toluene in the presence of 0.67 g. of p-toluenesulfonic acid to give p-methoxyphenyl 2-piperidino-l-cyclohexen-1-y1 ketone.
Example 38 Cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol A solution of p-methoxyphenyl 2-piperidino-l-cyclohexenl-yl ketone (obtained from a synthesis of the same scale as shown in Example 37) in 300 m1. of ethanol was hydrogenated in the presence of l g. of platinum oxide under an initial hydrogen pressure of 51 pounds. Two molar equivalents of hydrogen were absorbed during a period of 2.5 hours. The mixture was filtered through Filtercei diatomaceous earth. The filtrate was then evaporated to dryness and the residue dissolved in 250 ml. of ether. The ether solution upon standing produced crystals which were recovered by filtration and washed with ether. One g. of material was obtained having a melting point l52-l68 C. This material after recrystallization from methanol-ether was found to be the p-toluenesulfonic acid salt of cis-A-a(p-methoxyphenyl)2-piperidinocyclohexanemethanol of melting point l82l 83 C. Ultraviolet: A max. 223 (21,800); sh 256 (705); sh 262 (980); sh 268 1,360); 275 (1,530); 282 (1,280).
Analysis:
Calcd. for CgeHa N0 5:
C, 65.66; H, 7.84; N, 2.95; S, 6.74
Found: C, 65.27; H, 7.88; N, 2.89; S, 6.86
The ethereal filtrate above was stirred with 200 ml. of percent aqueous acetic acid for 9% hour. The aqueous layer was separated, then extracted once with ether, and the ether extract discarded. The aqueous layer was then cooled, basified with aqueous sodium hydroxide solution and extracted with methylene chloride (four portions of 75 ml. each. The extracts were combined, washed with water, saturated salt solution, dried by passing the solution through anhydrous sodium sulfate and evaporated to give 22.5 g. of oily material. This material was recrystallized from petroleum ether to give 21.4 g. (71 percent yield) of cis-A-a-(p-methoxyphenyl)-2- piperidinocyclohexanemethanol of melting point 7880 C. Ultraviolet: A max. 225 (1 1,500); 275 (1,500); 283 (1,300).
Analysis:
Calcd. for C H NO C, 75.20; H, 9.63; N, 4.62 Found: C, 75.17; H 9.88- N 4.47
The above configurations are simplified. For example, a truer representation of the cis form above would be the configurations (X) and (Y) below.
cis trans In the configuration (X) the p-methoxybenzoyl group (at 1) is attached by an axial bond (a) to the cyclohexane moiety (chair form) and the piperidino group (at 2) by an equatorial bond (e). While this would indicate the existence of a cis isomer with reversed grouping, i.e., p-methoxybenzoyl on an equatorial bond and piperidino on an axial bond, such an isomer is thermodynamically less stable under ordinary conditions. However, the optical isomers (Y) and (X) of the cis form are stable and thus the simplified cis configuration represents a mixture of (X) and (Y). 1n the trans form, the equatorial-equatorial positions of the vicinal substituents is the thermodynamically stable configuration and thus only one trans-p-methoxyphenyl 2-piperidinocyclohexyl ketone consisting of two optical forms, as for the cis compound, is obtained.
EXAMPLE 39 Cis-p-methoxyphenyl 2-piperidinocyclohexyl ketone A mixture of 139 g. (0.6 mole) of 2-(p-methoxybenzoyl)cyclohexanone, 153 g. (1.8 moles) of piperidine,
4800 ml. of toluene and 4.02 g. of p-toluenesulfonic acid monohydrate was refluxed for 20 hours in a vessel equipped with an azeotropic separator. A total of 10.1 ml. of water was collected. The reaction mixture was evaporated to dryness on a steam bath to give a residue which was dissolved in 1,200 ml. of ethanol and the thus-obtained solution was divided into four equal parts. Each part was hydrogenated in the presence of 1.5 g. of platinum oxide at an initial pressure of 50 pounds of hydrogen. Hydrogenation was stopped after the uptake of 1 molar equivalent. The time required for this procedure was 25 minutes to 55 minutes. Thereafter, the combined mixture was filtered through diatomaceous earth, and the solution was evaporated to dryness. A deep yellow oil was obtained which was dissolved in 1,200 ml. of ether and allowed to stand for 15 minutes. The mixture was thereupon filtered and a precipitate was collected weighing 5.3 g. The ethereal filtrate was stirred with 1 l. of 10 percent aqueous hydrochloric acid for 45 minutes. The acidic layer was separated, filtered and basified with 20 percent aqueous sodium hydroxide solution. The resulting oil which solidified after a short time was extracted with methylene chloride (five portions of 200 ml. each), the extracts were combined, washed with water, then with saturated salt solution, dried over anhydrous sodium sulfate and evaporated to give a crude product of l 16 g. Recrystallization of this crude product from petroleum ether gave 75 g. (42 percent yield) of colorless needles of cis-p-methoxyphenyl Zpiperidinocyclohexyl ketone having a melting point of 8688 C. Further recrystallization from petroleum ether for analytical purposes gave cis-p-methoxyphenyl 2-piperidinocyclohexyl ketone of melting point 86.5-88 C.
Ultraviolet: A max. 217 (11,850 273 (15,800); 278 (15,500).
Analysis:
Calcd. for C H NO C, 75.71; H, 9.03; N, 4.65 Found: C, 76.19; H, 9.19; N, 4.88
EXAMPLE 40 Trans-p-methoxyphenyl 2-piperidinocyclohexy1 ketone A solution of 68.3 g. (0.227 mole) of cisp-methoxyphenyl 2-piperidinocyclohexyl ketone was refluxed for 68 hours in 683 m1. of piperidine. The reaction mixture was thereupon evaporated to dryness to give 55 g. of a residual oil which was dissolved in 500 ml. of ether and extracted with four portions of ml. each of 10 percent aqueous acetic acid. The acid extracts were combined, cooled in ice and basified with 20 percent aqueous sodium hydroxide solution and thereupon extracted with four portions of ml. each of methylene chloride. The methylene chloride extracts were combined, washed with saturated salt solution, dried over anhydrous sodium sulfate and evaporated to give 22 g. of a colorless solid which was crystallized from 150 m1. of petroleum ether (boiling range from 30-60 C.) to give 12.05 g. of trans-p-methoxyphenyl Z-piperidinocyclohexyl ketone of melting point 100-l01 C. A second crop of 3.5 g. of the same material was also obtained; a total of 23 percent yield. Ultraviolet: A max. 216 (12,900); 271 (15,350).
Analysis:
Calcd. for C ,H, NO
C, 75.71; H, 9.03; N, 4.65 Found: C, 75.28; H, 8.66; N, 4.62
The original ether layer above contained also l-(p-methoxy-benzoyl)-l-cyclohexene, a yellow oil boiling at l45-155 C.
Analysis:
Calcd. for C H O .7 EXAMPLE 41 Cis-A-a-( p-methoxyphenyl )-2-piperidinocyclohexanemethanol v H (in t A solution of 'cis-p-methoxyphenyl Z-piperidinocyclohexyl ketone (3.01 g.; 0.01 mole) in 100 ml. of ethanol was subjected to hydrogenation inthe presence of platinum oxide (0.3 g.) atan' initial pressure of 53 pounds of hydrogen. One molar equivalent was absorbed in 25 hours. The mixture was filtered, and the filtrate was evaporated to dryness, giving 3.1 g. of an oily material. A.2 .9-g. portion of this oil was chromatographed over 150 g. of Florisil (anhydrous magnesium silicate) using 150-m1. portions of an eluant of 6 percent acetone-94percent Skellysolve B hexanes. The first four fractions containing Since the carbon atom of the methanol group of a-(p- 'methoxyfphenyl)-2-piperidinocyclohexanemethanol is asymmetric, it is obvious that besides the cis-A-alcohol, the cis-B- alcohol is possible (Example 42).
EXAMPLE 42" Cis-A- I and cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol 1 Solid cis-p-methoxyphenyl 2-piperidinocyclohexyl ketone (3.01 g.; 0.01 mole) was added, to an ice-cooled solution of sodium borohydride (3 g.) in 100 ml. of ethanol. The reaction mixture was then stirred at room temperature (22-25 C.) for a period of .16 hours. It was evaporated to dryness in vacuo at 40 C. To. the residue was added 100 ml. of water, and the mixture was then stirred for 30 minutes. The resulting oil was extracted three times with ether. The ether extracts were combined, washed with water, the water discarded, then washed with four 25-ml. portions of percent aqueous acetic acid. The acidic extract was washed once with ether, and the ether discarded. It was then cooled in ice and basified with percent sodium hydroxide solution. The reaction mixture was then extracted three times with ether, the extracts combined, washed with water, then with saturated salt solution, dried over anhydrous sodium sulfate and evaporated to give 3 g. of an oil. The oily material was crystallized from 50 ml. of petroleum ether (boiling range 30-60 C.) to give 1.8 g. of cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol, melting point 78-80 C.
The filtrate was evaporated todryness, and the residue was chromatographed on 60 g. of Florisil (anhydrous magnesium silicate). The column of Florisil was eluted twice with 150-m1. portions ofan eluantconsisting of 6 percent acetone and 94 percent Skellysolve B hexanes; four times with 150-ml. portions of an eluant consisting of 12 percent acetone and 88 percent Skellysolve B hexanes; and finally three times with 150- ml; portions of a percent acetone-80 percent Skellysolve B hexanes solution, giving 0.576 g. of cis-A-alcohol, which after recrystallization from petroleum ether had a melting point of 80-81 C. Elution with 50 percent acetone-50percent Skellysolve B hexanes (four portions of 150 ml. each) and acetone (two portions of '250 ml. each) gave 0.316 g. of cis-B-a-(pmethoxyphenyl)-Z-piperidinocyclohexanemethanol, which after recrystallization from ether weighed 0.1 g. and had a melting point of 135-l 36 C.
These cis alcohols A and B can also be produced from cis-pmethoxyphenyl Z-piperidinocyclohexyl ketone by reduction with lithium aluminum hydride.
EXAMPLE 43 Cis-A- and cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol A solution of 0.9 g. (Bmmoles) of cis-p-methoxyphenyl 2 piperidinocyclohexyl ketone in 25 ml. of ether was added dropwise during 5 minutes to a solution containing 1 g. of lithium aluminum hydride in 100 ml. of ether..The mixture was stirred during a period of 22 hours and was then decomposed by successive addition of 1 ml. of water, 1 ml. of 15 percent aqueous sodium hydroxide and 3 ml. of water. The resulting suspension was stirred for a period of 2 hours. It was then filtered and the solid washed with ether. The combined filtrate and washings were extracted with three portions of 30 ml. each of 10 percent aqueous acetic acid, and the combined acidic extracts were backwashed once with ether. The acidic extract was then basified with 15 percent aqueous sodium hydroxide and extracted three times with ether. The combined ether extracts were washed with water, saturated salt solution, and dried by passage through anhydrous sodium sulfate. The
resulting dried solution was evaporated to give 0.77 g. of a colorless oil. This oil was chromatographed over 35 g. of Florisil (anhydrous magnesium silicate) by eluting with an eluant consisting of 6 percent acetone and 94 percent Skellysolve B hexanes. The first four fractions of 150 ml. each gave 0.607 g. (67 percent yield) of cis-A-a-(p-methoxyphenyl)-2- piperidinocyclohexanemethanol(melting point -81 C.). Further elution with an eluant consisting of 12 percent acetone and 88 percent Skellysolve B hexanes gave, in four -ml. fractions, 0.209 g. of cis-B-a-(p-methoxypheny)-2- piperidinocyclohexanemethanol of melting point l34-l35 C. (23 percent yield).
EXAMPLE 44 Trans-C-a-(p-methoxyphenyl)-2-piperidinocyc1ohexanemethanol 1n the manner given in Example 41, trans-p-methoxyphenyl Z-piperidinocyclohexyl ketone (3.01 g.; 0.01 mole) was hydrogenated in ethanol solution in the presence of 0.5 g. of platinum oxide catalyst at 53 pounds initialhydrogen pressure. The solution after 138 minutes of hydrogenation was filtered through Filtercel diatomaceous earth. The filtrate was evaporated giving 3 g. of a solid of melting point 14l-l45 C. This solid was crystallized from methanol to give 2.5 g. of colorless needles of trans-C-a-(p-methoxyphenyl)-2- piperidinocyclohexanemethanol of melting point l48-l49 C. A second crop of 0.25 g. of product was obtained from the filtrate; the total yield was 91 percent. Ultraviolet: 225 (12,150); 275 (1,500); 281 (1,300).
Analysis:
Calcd. for G i-1 EXAMPLE 45 20; H, 9.63; N, 4.62 l
5. Found: 5. 8; H, 9.81; N, 4.82
thereupon extracted twice with methylene chloride. The combined extract was washed with water, saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated to give 0.6 g. of a colorless solid of melting point 129-l40 C. Crystallization from methanol yielded 0.325 g. of recovered starting material of melting point l45l47 C. The filtrate was evaporated to dryness and the residue was chromatographed over g. of Florisil (anhydrous magnesium silicate). The column containing the Florisil was eluted with 400 ml. of a solution containing 6 percent acetone and 94 percent Skellysolve B hexanes. The filtrates from the solution were combined and evaporated, and the residue was recrystallized from petroleum ether (boiling range 30-60 C.) to give 77 mg. of a product melting at 8l82 C., namely trans-D-a- (p-methoxyphenyl)-2-piperidinocyclohexanemethanol. Ultraviolet: 226 (1 1,000); 276 1,650); 282 1,450).
Analysis:
Calcd. for C H,,NO,:
EXAMPLE 46 Trans-C- and trans-D-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol A solution of trans-p-methoxyphenyl 2-piperidinocyclohexyl ketone (23.9 g.; 0.0795 mole) in 575 ml. of ether was added to a solution of 24 g. of lithium aluminum hydride in 2,400 ml. of ether over a period of 30 minutes. The mixture was then stirred for about hours. It was thereupon decomposed successively with 24 ml. of water, 24 ml. of 15 percent aqueous sodium hydroxide and 72 ml. of water. The resulting mixture was filtered and the cake was washed with ether. The combined filtrate and washings were evaporated to dryness to give 22.5 g. of a colorless oily solid which upon crystallization from 75 ml. of ethanol gave 13.4 g. of trans-C-a-(p-methoxyphenyl)-2-pi eridinocyclohexanemethanol of melting point l45- 1 46 C.
The filtrate was evaporated to dryness. The residue was dissolved in 50 ml. of methylene chloride and chromatographed over 460 g. of Florisil (anhydrous magnesium silicate). The column containing the Florisil was eluted with 750 ml. of an eluant consisting of 3 percent acetone and 97 percent Skellysolve B hexanes. This fraction yielded 81 mg. of solid which was discarded; thereupon were taken 19 250-ml. portions using an eluant consisting of 6 percent acetone and 94 percent Skellysolve B hexanes. These fractions were combined and evaporated to give 5.31 g. of solid melting at 80-82 C. Further elution with an eluant consisting of 15 percent acetone and 85 percent Skellysolve B hexanes (4 fractions of 250 ml. each) gave 0.535 g. of solid melting at 808l C. Recrystallization of the combined material from petroleum ether afforded 4.6 g. of trans-D-a-(p-methoxyphenyl)-2- piperidinocyclohexanemethanol of melting point 8 l-82 C.
Nuclear magnetic resonance spectrum (in CDCl;,) showed methoxy at 229 cps; broad band for benzylic hydrogen centered at 278.5 cps.
Found:
EXAMPLE 47 Cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol A solution was prepared having 30.3 g. (0.1 mole) of cis-A- a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol in 200 ml. of trifluoroacetic acid, under cooling with ice. The mixture was then stirred at room temperature for 20 minutes, giving a greenish solution which was again cooled in ice. To this solution was added 150 g. of ice followed by 500 ml. of water and then 500 ml. of 20 percent aqueous sodium hydroxide. The mixture was stirred for 15 minutes and was thereupon extracted with five portions of 200 ml. each of methylene chloride. The methylene chloride extracts were combined, washed with water, saturated salt solution, then dried by passage through anhydrous sodium sulfate and evaporated to Analysis:
Calcd. for C,,H ,NO,:
C, 75.20; H, 9.63; N, 4.62 Found: C, 74.96; H, 9.62; N, 4.55
EXAMPLE 48 a-( 3,4,5-Trimethoxyphenyl )-2-( hexahydrol H-azepinl yl)cyclohexanemethanol hydrochloride OCH;
H 60H; N
A mixture of g. (0.12 mole) of 2-(3,4,5-trimethoxybenzoyl)cyclohexanone, 35.6 g. (0.36 mole) of hexamethyleneimine, 960 ml. of toluene and 0.8 g. of ptoluenesulfonic acid was refluxed for 7.5 hours in a nitrogen atmosphere in a vessel equipped with an azeotropic separator. A total of 1.8 ml. of water was collected. The mixture was thereupon evaporated to dryness, the residue was dissolved in 250 ml. of ethanol and hydrogenated in the presence of 1.2 g. of platinum oxide at an initial pressure of 5 1.5 pounds of hydrogen. Two molar equivalents of hydrogen were absorbed during 5 hours. The reaction mixture was then filtered through diatomaceous earth (Filtercel), and the filtrate was evaporated to dryness. The thus-obtained residue was dissolved in 400 ml. of ether. The ether solution was stirred with 400 ml. of 10 percent hydrochloric acid for 0.5 hours, and the resulting suspension was filtered. The obtained solid was washed with ether to give 18.2 g. of material. This material was crystallized from 250 ml. of methanol to give 16.4 g. of a- 3 ,4,5-trimethoxyphenyl )-2-(hexahydrol l-l-azepinl yl)cyclohexanemethanol hydrochloride of melting point 244-246 C.
Ultraviolet: sh 288 (8,250); 268 (757); 276 (608).
Analysis:
Calcd. for C rr nza-H01;
C, 63.83; H, 8.77; Cl, 8.56; N, 3.38 Found: C, 63.95; H, 9.13; Cl, 8.47; N, 3.58 Workup of the aqueous hydrochloric acid filtrate above provided another 0.7 g. of a-(3,4,5-trimethoxyphenyl)-2- hexa-hydrol l-l-azepinl -yl)cyclohexanemethanol v hydrochloride of melting point 242-243 C.; thus a total yield of 34 percent.
EXAMPLE 49 l-l-azepinl reaction mixture was added a solution of 102 g. 0.6 mole) of 1 p-anisoyl chloride in 240 ml. of purified chloroform during a period of 2 hours while keeping the temperature between 5 to C. A suspension resulted which was stirred for a period of about hours at room temperature. The suspension was thereupon filtered, and the precipitate washed with ether, the ether wash being discarded. The precipitate was 46.8 g. of triethylamine hydrochloride of melting point 3-254 C.
' The chloroform filtrate was evaporated to dryness. The resulting residue was dissolved in 900 ml. of ethanol and hydrogenated in three portions, each in the presence of l g. of platinum oxide at a hydrogen pressure of about 50-52 pounds. After the absorption of about 80 percent of the hydrogen had taken place, the hydrogenation stopped and another 1 g. of platinum oxide was added. Two molar equivalents of hydrogenwere absorbed during 22 hours. The resulting thick suspension was filtered and the precipitate washed with ethanol. The moist cake was refluxed with 1,500 ml. of ethanol, .filtered and allowed to crystallize. The first crop of crystals amounted to 80.7 g.,of cis-A-a-(p-methoxyphenyl)-2- (hexahydrolH-azepinl -yl)cyclohexanemethanol hydrochloride of melting point of 230-23 1 C. A second crop of 20 g. was also collected. Further recrystallization did not change the melting point of the product.
Ultraviolet: )1 maxy226 12,150); 276 1,550); 282 1,350).
Analysis:
Calcd. for c,,,H ,,No,-Hcl= C, 67.87; H, 9. l2; Cl, 10.02; Found: C, 67.27; H, 9.14; Cl,
EXAMPLE 50 a(p-Trifluoromethylphenyl)-2-(hexahydro-lH-azepin-lyl)cyclohexanemethanol hydrochloride In the mariner given in Example 49, 0.1 mole of triethylamine and 0.1 mole of l-hexamethyleneimino-lcyclohexene was reacted irichloroform solution with 0.1 mole of p-trifluoromethylbenzoyl chloride. The resulting product was hydrogenated in 300 ml. of methanol in the presence of l g. of platinum oxide. Two molar equivalents of hydrogen were absorbed in 3.5 hours. The hydrogenation reaction mixture was filtered through diatomaceous earth (Filtercel) and the filtrate evaporated to dryness. The resulting solid was suspended in 200 ml. of ether and 200 ml. of 10 percent aque ous acetic acid, and the suspension was stirred for a period of 3.5 hours. The suspension was then filtered, and the solid washed with water followed by ether. Thirteen and four-tenths g. of solid was thus obtained which was recrystallized from methanol giving a-(p-trifluoromethylphenyl)-2-(hexa-hydro-1 H-azepin-l-yl)cyclohexanemethanol hydrochloride of melting point 263-264 C. v
Ultraviolet: A max. 216 (8,050); 252 (298); 257 (357); 263 (364);269(290).
Analysis:
Calcd. for C ,,H F NO-HC1:
C, 61.29; H, 7.46; Cl, 9.05; F, 14.54; found: C, 60.89; H, 7.58; Cl, 9.17;
EXAMPLE 51 N, 3.57 F, 13.96; N, 3.66
ml. of ethanol, heated to reflux, filtered and the solution allowed to crystallize. Filtration yielded 12.25 g. of a-(pchlorophenyl )-2-( hexa-hydrol H-azepin- 1 -yl)cyclohexanemethanol hydrochloride of melting point 274-275 C. Ultraviolet: A max. 221 (10,000); sh 226 (8,200); 252 (182); 258 (210); 267 (260); 275 (193).
Analysis:
Found: N, 3.98
EXAMPLE 52 a-Phenyl-2-( hexahydrolH-azepinl -yl)cyclohexanemethanol hydrochloride in the manner given in Example 49, 0.1 mole of triethylamine, 0.1 mole of l-hexamethylimino-l-cyclohexene and 0.1 mole 14 g.) of benzoyl chloride were reacted, and the reaction product hydrogenated in methanol in the presence of platinum oxide for a period of 2.5 hours. The mixture was filtered, evaporated to dryness and the solid residue was suspended in 200 ml. of ether and 200 ml. of 10 percent aq ueous acetic acid. The mixture was stirred for 0.5 hour and the resulting suspension filtered yielding a solid which was washed with water followed by ether. The thus-obtained product, 3.6 g., was recrystallized from methanol to give 2.8 g. of a-phenyl- 2-( hexahydro- 1 l-l-azepin- 1 -yl )cyclohexanemethanol hydrochloride of melting point 276277" C. Ultraviolet: A max. 247 (107.); 252 (130); 257 (178); 263 (130);267(91). 7
Analysis:
Calcd. for C H NO'HCl:
C, 70.45; H, 9.34; CI, 10.95; N, 4.33 Found: C, 70.22; H, 8.94; CI, 11.03; N, 4.45
EXAMPLE 53 a-( 3,4-Methylenedioxyphenyl )-2-(hexahydrol l-l-azepin- 1 yl)cyclohexanemethanol hydrochloride 1 A solution of piperonyloyl chloride in ml. of chloroform was added during 1.5 hours with cooling and stirring to a solution of l-hexamethyleneimino-l-cyclohexene (53.6 g.; 0.3 mole) and 30.3 g. (0.3 mole) of triethylamine in 126 ml. of chloroform at a'temperature below 10 C. The reaction mixture was then stirred for about 20 hours at a temperature between 23-26 C. The thus-obtained suspension was filtered to give 23 g. of triethylamine hydrochloride melting at 252254 C. The filtrate was evaporated to dryness, the residue was dissolved in 600 ml. of ethanol and hydrogenated in the presence of 3 g. of platinum oxide'at an initial pressure of 52.5 pounds of hydrogen. After 6 hours, a l g. quantity of platinum oxide catalyst was added and hydrogenation continued for another 16 hours. The resulting suspension was filtered and the solid, consisting of the product and catalyst, was refluxed in 1,800 ml. of ethanol; this suspension was. filtered, evaporated to 900 ml. and allowed to crystallize, yielding 50 g. of a-( 3 ,4-methylenedioxyphenyl)-2-(hexahydro-ll-l-azepin-1- yl)cyclohexanemethanol hydrochloride of melting point 235236 C.
Work-up of the filtrate by evaporation and stirring with 400 ml. of 10 percent aqueous acetic acid and 450 ml. of ether gave another 10 g. of solid material which after recrystallization from ethanol gave 5 g. of a-(3,4-methylenedioxyphenyl)- 2-(hexa-hydrol l-l-azepinl yl)cyclohexanemethanol hydrochloride of melting point 233-234 C.
Ultraviolet: A max. 235 (4,150); 286 (4,050).
Analysis:
Calcd. for c,,,i-l,,,No,-Hcl:
C, 65.29; H, 8.22; Cl, 9.64; N, 3.81
Found: C, 65.18; H, 8.38; CI, 9.93; N, 3.79
The above compound is useful as a diuretic and oral antidiabetic agent.
EXAMPLE 54 a-( 3 ,4-Dimethoxyphenyl )-2-( hexahydro- 1 H-azepin- 1 -yl) cyclohexanemethanol hydrochloride In the manner given in Example 53, l-hexamethyleneiminol-cyclohexene was reacted with 3,4-dimethoxybenzoyl chloride (53.6 g.; 0.3 mole) in the presence of triethylamine. The resulting product was hydrogenated in the presence of platinum oxide and the mixture was worked up as in Example 53 giving 52.2 g. of a-(3,4-dimethoxyphenyl)-2-(hexahydrolH-azepin-l-yl)cyclohexanemethanol hydrochloride of melting point 225-228 C. in the first crop. Additional material was obtained by the work-up of filtrates with acetic acid and ether. A total yield of about 50 percent was obtained. The analytical sample, prepared by recrystallization from ethanol, gave a-(3,4-dimethoxyphenyl)-2-(hexahydro-lH-azepin-lyl)cyclohexanemethano1 hydrochloride of melting point 225226 C. Ultraviolet: A max. 230 (8,550); 279 (2,950); sh 285 (2,550).
24; C, 65.88; H, 9.19; Cl, 3
9. Found: 9.
EXAMPLE 55 Cis-B-a-(p-methoxyphenyl)-2-(hexahydro-lH-azepin-lyl)cyclohexanemethanol and the hydrochloride thereof To 240 ml. of trifiuoroacetic acid, cooled to 5 C. was added, all at once, 38 g. (0.12 mole) of cis-A-a-(p-methoxyphenyl )-2-( hexahydrol H-azepin- 1 -yl)cyclohexanemethanol with stirring. The mixture was kept stirring for 20 minutes whereby the temperature reached about 40 C. Thereupon, the solution was cooled, ice was added, followed by 600 ml. of water and then 600 ml. of 20 percent aqueous sodium hydroxide. The mixture was then extracted with five 200-ml. portions of methylene chloride. The extracts were combined, washed with saturated salt solution, dried by passing through anhydrous sodium sulfate, and the filtrate evaporated to give 37.9 g. of a yellowish oil. This oil was dissolved in 150 ml. of petroleum ether (boiling range 30-60 C.) and allowed to crystallize in the refrigerator overnight; 13.6 g. of crystals were recovered by filtration. These crystals were recrystallized from 50 ml. of ether to give 10.1 g. of cis-B-a-(p-methoxyphenyl)-2-(hexahydro-1 H-azepin-l-y1)cyclohexanemethanol of melting point 94-95.5 C. Ultraviolet: A max. 225 (12,750); 275 (1,550); 281 (1,350).
Analysis:
Calcd. for C H NO Found:
The hydrochloride of cis-B-a-(p-methoxyphenyl)-2-(hexahydro-lI-I-azepin-l-yl)cyclohexanemethanol was prepared with 1.5 N ethereal hydrogen chloride. After two crystallizations from methanol-ether, colorless needles were obtained melting at 188-l 89 C.
Ultraviolet: A max. 226 (12,700); 275 (1,450); 281 (1,250).
Analysis:
Calcd. for C H ,N0,-HCl:
C, 67.87; H, 9.12; Cl, Found: C, 67.24; H, 9.36; Cl,
Analysis:
Calcd. for C H NO HCI:
C, 68.26; H, 8.59; Cl, 10.08; N, 3.98 Found: C, 67.92; H, 8.55; Cl, 10.06; N, 4.05
EXAMPLE 56 a-(3,4,5-Trimethoxyphenyl)-2-piperidinocycloheptane methanol hydrochloride A. l-Piperidino- 1 -cycloheptene.
A mixture of 224.2 g. (2 moles) of cycloheptanone, 340 g. (4 moles) of piperidine, 400 ml. of benzene and 2.2 g. of ptoluenesulfonic acid was refluxed for a period of 16 hours in a nitrogen atmosphere, using an azeotropic separator. A total of 5 ml. of water was collected. Since this was less than the calculated amount of water produced during the reaction, the separator was replaced with a Soxhlet extractor containing 322 g. of crystalline sodium aluminum silicate, Na [(Al o (SiO [Linde molecular sieve, Type 4A; see The Merck Index, Merck and Co., Inc. 1960, Seventh Edition, page 1,592], and the mixture was refiuxedfor 3 days. After the solvent was removed by distillation from the reaction mixture, 319.7 g. of l-piperidino-l-cycloheptene of boiling point -l3 1 C. at 17 mm. (89 percent yield) was obtained.
B. a-(3,4,5-Trimethoxyphenyl)-2-piperidinocyclohep tanemethanol hydrochloride In the manner given in Example 49, Part B, 23 g. (0.1 mole) of 3,4,5-trimethoxybenzoyl chloride, 17.9 g. (0.1 mole) of lpiperidino-l-cycloheptene and triethylamine (0.1 mole) were reacted at low temperature in a chloroform solution. The resulting product was hydrogenated in methanol for a period of 3 hours during which 2 molar equivalents of hydrogen were consumed. The resulting reaction mixture was then filtered and evaporated, and the residue stirred with ml. of water and 150 ml. of methylene chloride for a period of 0.5 hour. The methylene chloride layer was separated and stirred with 250 ml. of 10 percent aqueous hydrochloric acid for one-half hour. The resulting suspension was filtered and the solid washed with water to give 7.5 g. of a-(3,4,5-trimethoxyphenyl)-2-piperidinocycloheptanemethanol hydrochloride of melting point 237-238 C. This material was recrystallized from methanol to give a-(3,4,5-trimethoxyphenyl)-2-piperidinocycloheptanemethanol hydrochloride of melting point 243-244 C.
Ultraviolet: sh 266 (8,250); sh 234 (6,800); A max. 270 (782); sh 278 (546).
Analysis:
Calcd. for C,,H,,,,NO,-HC1:
C, 63.82; H, 8.77; Cl, 8.5 Found: C, 63.43; H, 8.85; Cl, 8.6
The work-up of the methylene chloride layer gave 1.5 g. of cycloheptyl 3,4,5-trimethoxyphenyl ketone of melting point 7677 C. in colorless crystalline plates.
Analysis:
Calcd. for C H O Found: C, 69.64; H, 8.24
EXAMPLE 5 7 a-( 3 ,4,5-Trimethoxyphenyl )2-( 1-pyrolidinyl)cyclohexanemethanol and hydrochloride A mixture of 17.5 g. (0.06 mole) of 2-(3,4,5-trimethoxybenzoyl)cyclohexanone, 12.8 g. (0.18 mole) of pyrrolidine and 480 ml. of benzene was refluxed for 1.25 hours using an azeotropic separator; 1.5 ml. of water was collected. The mixture was evaporated to dryness to give a yellow oil. A small sample was crystallized twice from ether to give yellow prisms melting at 1l8120 C. and constituting 3,4,5-trimethoxyphenyl 2-( 1-pyrrolidinyl)- l-cyclohexen-l-yl ketone. Ultraviolet: in ether A max. 262 (11,50 358 (5,500); in ethanol sh 220 17,000); 269 (7,700); 372 (7,050).
Analysis:
" Calcd. for C NO4 C, 69.54; H, 7.88; N. 495
Found: C, 69.91; H, 8.08; N, 3.76
The crude 3,4,5-trimethoxyphenyl 2-( l-pyrrolidinyl)-lcyclohexen-l-yl ketone was dissolved in 250 ml. of ethanol and hydrogenated in the presence of 0.6 g. of platinum oxide. Two molar equivalents of hydrogen were taken up in 6 hours. The mixture was then filtered through diatomaceous earth and the filtrate evaporated to dryness. The residue was stirred with 200 ml. of 10 percent aqueous hydrochloric acid and 250 ml. of ether for 0.5 hour. The aqueous layer was separated, extracted with ether, basified with sodium bicarbonate and extracted with four l25-ml. portions of methylene chloride. The methylene chloride extracts were combined, washed with water, then with saturated salt solution, dried by passing through anhydrous sodium sulfateand evaporated to give 16.5 g. of solid. This solid was recrystallized from ether to give 9.7 g. of a-(3,4,5-trimethoxyphenyl)-2-( l-pyrrolidinyl)cyclohexanemethanol of melting point l21-122 C. A second crop of 2 g. of the alcohol was obtained with a melting point of 1 l9l20 C. The total yield was 56 percent. Ultraviolet: .rh 226 (9,200); A max. 269 (744); sh 280 (542).
Analysis:
Calcd. for C,,,H ,NO
Found:
Analysis:
Calcd. for C,, H ,NO ,-HCI:
C, 62.24; H, 8.36; Cl, 9.19; N, 3.63 Found: C, 62.31; H, 8.82; Cl, 9.15 3.65
EXAMPLE 58 3 ,4,5 -Trimethoxy-a-( Z-pipe ridinocyclopentyl)benzyl alcohol [a-( 3 ,4,5-trimethoxyphenyl)-2-piperidinocyclopentanemethanol] A. 3,4,5-Trimethoxyphenyl ketone.
A solution of 15.1 g. (0.1 mole) of l-piperidino-l-cyclopentene was added, in a nitrogen atmosphere, with ice cooling, to a solution of 10.1 g. (0.1 mole) of triethylamine in 42 ml. of chloroform (purified by passage through a column of basic alumina). To this solution was added a solution of 23.0 g. (0.1 mole) of 3,4,5-trimethoxybenzoyl chloride in 40 ml. of chloroform, over a period of 1.5 hours, while the temperature of the reaction mixture was kept at 5-10 C. The mixture was then stirred overnight at room temperature (22-25 C.) and was filtered to give 6.91 g. of triethylamine hydrochloride. The filtrate was evaporated to dryness at 50 C. The residue was dissolved in 250 ml. of ethanol, 12 g. (0.2 mole) of acetic acid and 1 g. of platinum oxide were added and hydrogenation was carried out at an initial pressure of 51 pounds. Two moles of hydrogen were taken up during 1 hour and 28 minutes; more than 90 percent of the calculated hydrogen was absorbed in the first half hour. The mixture was then filtered and evaporated to dryness. A mixture of 100 ml. of ether and 100 ml. of percent aqueous hydrochloric acid was added, and the obtained reaction mixture was stirred for 1.5 hours. The layers were separated and the aqueous layer was extracted once with ether. The ether extracts were washed with water to give the neutral layer." The acidic layer was cooled in ice and basified with 20 percent aqueous sodium hydroxide. it was extracted twice with ether, the combined ether extract 2'piperidinocyclopentyl was washed with water, saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated to give 14.6 g. of a brown oil which solidified on standing in vacuo overnight. The solid was dissolved in 150 ml. of petroleum ether (boiling range between 30-60 C.) and 20 ml. of ether and cooled with ice for 2 hours. The resulting suspension was decanted, thus providing solid A and filtrate B. Filtrate B was evaporated to about half the volume and cooled. The resulting solid, 1.2 g. of melting point l20-l 30 C., was removed by filtration. Recrystallization of this solid from ether gave colorless needles of melting point 133.5-l 345 C. The melting point of this material was not changed by recrystallization from ether. Ultraviolet, infrared and NMR spectra and also carbon, hydrogen and nitrogen analysis indicated that this product was a mixture.
Solid A and the residue from filtrate B were combined to give 13.3 g. of a yellow solid. This solid was dissolved in 50 ml. of benzene and chromatographed over 400 g. of neutral alumina, taking six benzene fractions of 250 ml. each. Fraction 2 contained 2.378 g. of material which was crystallized from 20 ml. of Skellysolve B hexanes to give 1.5 g. of 3,4,5-trimethoxyphenyl Z-piperidinocyclpentyl ketone of melting point 7980 C. Ultraviolet: A max. 217 (29,400); 283 (10,700).
Analysis:
Calcd. for C, H,,,N0,:
Found:
The above neutral layer contained a solid fraction of 8.78 g. which after recrystallization from Skellysolve B hexanes gave 6.8 of cyclopentyl 3,4,5trimethoxyphenyl ketone of melting point 46-47.5 C.
B. 3,4,5-Trimethoxy-a-(Z-piperidinocyclopentyl)benzyl alcohol A solution of 1.2 g. (3.48 mmoles) of 3,4,5-trimethoxyphenyl 2-piperidinocyclopentyl ketone in 25 ml. of ether was added over a period of 5 minutes to a solution of 1.2 g. of lithium aluminum hydride in 100 ml. of ether, and the mixture was stirred for 21 hours. It was then decomposed by successive addition of 1.2 g. ofwater, 1.2 ml. of 15 percent aqueous sodium hydroxide and 3.6 ml. of water. The thus-obtained reaction mixture was stirred for a period of 2 hours giving a suspension. This suspension was filtered and the solid washed with ether. The ether washing and the ether filtrate were combined, dried by passage through anhydrous sodium sulfate and evaporated to give 1.2 g. of an oil. The oil was chromatographed over 48 g. of Florisil (anhydrous magnesium silicate). Elution with five 100-m1. portions of a mixture consisting of 10 percent acetone and 90 percent Skellysolve B hexanes gave 0.136 g. of an oil. Elution with five portions of 100 ml. each of 20 percent acetone-80 percent Skellysolve B hexanes mixture gave 0.582 g. of oil. After standing in vacuo for one week, the oil crystallized to give a solid of melting point -88 C. This solid was recrystallized from ether-petroleum ether to give a 3,4,5- trimethoxy-a-(Z-piperidinocyclopentyl)benzyl alcohol melting at 9 l-92 C. Ultraviolet: sh 224 (9,100); sh 234; sh 269 (849); sh 278 (660).
Analysis:
Calcd. for CZQHMNO4:
C, 68. Found: C, 68.
Further elution with 30 percent acetone-70 percent Skellysolve B hexanes (five portions of ml. each) gave 0.140 g. and elution with 50 percent acetone-50 percent Skellysolve B hexanes mixture (five portions of 100 ml. each) gave 0.170 g. of solids. A 75 percent acetone-25 percent Skelly-solve B hexanes mixture (five portions of 100 ml. each) gave 0.087 g. and elution with acetone (two portions of 100 ml. each) gave 0.154 g. of solids..These solid fractions were combined and recrystallized from petroleum ether (boiling range 30-60 C.)
EXAMPLE 59 3,4,5-Trimethoxy-a-(Zpyrrolidinocyclopentyl)benzyl alcohol [a-(3,4,5-trimethoxyphenyl)-2-pyrrolidino-cyclopentanemethanol] A mixture of 8.35 g. (0.03 mole) of 2-(3,4,5-trimethoxybenzoyl)cyclopentanone, 6.5 g. (0.09 mole) of pyrrolidine, 240 ml. of benzene and 0.2 g. of p-toluenesulfonic acid was refluxed under a nitrogen atmosphere for-21 hours using an azeotropic separator; 0.5 ml. of water was collected. The solution was evaporated to dryness, 3,4,5-trimethoxyphenyl 2-pyrrolidino-l-cyclopenten-1-y1 ketone being obtained as a residue. This residue was dissolved in 100 ml. of methanol and hydrogenated in the presence of 0.3 g. of platinum oxide at an initial pressure of 54 pounds. One molar equivalent of hydrogen was taken up over a period of 4 hours whereupon the hydrogenation was stopped. The mixture was filtered through diatomaceous earth, and the filtrate evaporated to dryness, 3,4,5-trimethoxyphenyl 2-pyrrolidinocyclopentyl ketone being obtained as a reside. One-half of this product (5 g.; 0.015 mole) was dissolved in 100 ml. of benzene. This solution was added during minutes to a solution of 5 g. of lithium aluminum hydride in 200 ml. of ether, and the mixture was refluxed with stirring for a period of 3 hours. It was then decomposed by successively adding 5 ml. of water, 5 ml. of percent aqueous sodium hydroxide and 15 ml. of water. The suspension was filtered, and the solid washed with ether. The filtrate and the ether washings were combined, extracted with 10 percent hydrochloric acid (four portions of 50 ml. each) and the acidic extracts were basified by the addition of aqueous sodium hydroxide. The basified solution was extracted with four portions (each 50 ml.) of methylene chloride. The methylene chloride extracts were combined, washed with water, then with saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated to give 4.5 g. of a yellow oil. This yellow oil was dissolved in ml. of methylene chloride and chromatographed over 200 g. of Florisil (anhydrous magnesium silicate). The elution was carried out with five portions of 200 ml. each of 50 percent acetone-50 percent Skellysolve B hexanes. The eluates were concentrated to give 0.41 g. of solid which was recrystallized from Skellysolve B hexanes to give 3,4,5-trimethoxy-a-(2-pyrrolidinocyclopentyl)benzyl alcohol of melting point 85-86 C Ultraviolet: sh 227 (9,300); A max. 269 (788); sh 278 (573). NMR showed H on carbon bearing the OH as a doublet centered at 316.5 cps 3 cps).
Analysis:
Calcd. for C, H NO,:
C, 68.03; H, 8.71; N, 4.18 Found: C, 67.50; H, 8.73; N, 4.43
Elution of the above column with five portions of 200 ml. each of acetone gave after evaporation 0.58 g. of a solid, which was crystallized from ether and thereupon from tetrahydrofuran-Skellysolve B hexanes to give isomeric 3,4,5- trimethoxy-a-(2-pyrrolidinocyclopentyl)benzyl alcohol of melting point 147-148 C.
Ultraviolet: sh 225 (8,950); A max. 270 1,100); sh 227 (567). NMR showed H on carbon bearing the OH as a doublet centered at 291 cps (j= 5 cps).
Analysis:
Calcd. for C H NQ:
C, 68.03; H, 8.71; N, 4.18 Found: C, 67.70; H, 8.90; N, 4.25
EXAMPLE 60 p-Ethoxyphenyl 2-piperidino-1-cyclohexen-1-yl ketone In the manner given in Example 31, Z-(p-ethoxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluene sulfonic acid to give p-ethoxyphenyl 21- piperidinol -cyclohexen- 1 -yl ketone.
EXAMPLE 61 p-Benzyloxyphenyl 2-pyrrolidino- 1 -cyclohexen- 1 -yl ketone In the manner given in Example 31, 2-(p-benzyloxybenzoyl)-cyclohexanone was reacted with pyrrolidine in the presence of p-toluenesulfonic acid to give p-benzyloxyphenyl 2-pyrrolidino-1-cyclohexen- 1 -yl ketone.
EXAMPLE 62 p-Benzyloxyphenyl Z-piperidino-l-cyclohexen1-yl ketone 1n the manner given in Example 31, Z-(p-benzyloxybenzoyl)-cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-benzyloxyphenyl Z-piperidino- 1 -cyclohexen 1 -yl ketone.
EXAMPLE 63 p-( 2-Hydroxyethoxy)phenyl 2-piperidino-1-cyclohexen l-yl ketone In the manner given in Example 31, 2-[p-(2-hydroxyethoxy)-benzoyl]cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-(2-hydroxyethoxy)phenyl 2-piperidinol-cyclohexen-l-yl ketone.
EXAMPLE 64 o-Methoxyphenyl Z-piperidino-l-cyclohexen-l-yl ketone In the manner given in Example 31, 2-(o-methoxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give o-methoxyphenyl 2- piperidino- 1 -cyclohexen- 1 -y1 ketone.
EXAMPLE 65 o-Hydroxyphenyl Z-piperidino-l-cyclohexen-l-yl ketone 1n the manner given in Example 31, Z-(o-hydroxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give o-hydroxyphenyl 2- piperidino- 1 -cyclohexen- 1 -yl ketone.
EXAMPLE 65A p-Hydroxyphenyl 2-piperidino- 1 -cyclohexen- 1 -yl ketone In the manner given in Example 31, 2-(p-hydroxybenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-hydroxyphenyl 2- piperidino-l-cyclohexen-1-yl ketone.
EXAMPLE 66 2-Methoxy-4-methylphenyl 2-piperidino- 1 -cyclohexenl -yl ketone.
In the manner given in Example 31, 2-(2-methoxy-4- methylbenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give 2-methoxy-4- methylphenyl Z-piperidino-l-cyclohexen-1-yl ketone.
EXAMPLE 67 EXAMPLE 68 p-Trifluoromethylphenyl ketone 2-piperidino- 1 -cyclohexenl -yl In the manner given in Example 31, Z-(p-trifluoromethylbenzoyl)cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give ptrifluoromethylphenyl 2-piperidino-l-cyclohexcnl-yl ketone.
EXAMPLE 69 p-Allyloxyphenyl Z-piperidino- 1 -cyclohexenl -yl ketone In the manner given in Example 31, 2-(p-allyloxybenzoyl)- cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p-allyloxyphenyl Z-piperidinol-cyclohexen-1-yl ketone.
EXAMPLE 70 p-( Methylcarbamoyloxy)phenyl Z-piperidinol -cyclohexen- 1 -y1 ketone In the manner given in Example 31, Z-[p-(methylcarbamoyloxy)-benzoyl]cyclohexanone was reacted with piperidine in the presence of p-toluenesulfonic acid to give p- (methylcarbamoyloxy)phenyl 2-piperidinol -cyclohexenl -y] ketone.
EXAMPLE 7l 3 ,4-Methylenedioxyphenyl 2-( hexahydrol I-I-azepin l -yl l-cyclohexenl -yl ketone In the manner given in Example 31, 2-(3,4-methylenedioxybenzoyl)cyclohexanone was reacted with hexamethylencimine in the presence of p-toluenesulfonic acid to give 3 ,4-methylenedioxyphenyl Z-(hexahydrol I-l-azepin- 1- yl)- l -cycIohexen-l-yl ketone.
EXAMPLE 72 p-Chlorophenyl 2-(2-isopropylpyrrolidino)-l-cyclohexenl-yl ketone.
In the manner given in Example 31, 2-(p-chlorobenzoyl)- cyclohexanone was reacted with 2-ispropylpyrrolidine in the presence of p-toluenesulfonic acid to give p-chlorophenyl 2- (2-isopropylpyrrolidino 1 -cyclohexenl -yl ketone.
EXAMPLE 73 p-Hydroxyphenyl 2-octamethyleneimino- 1 -cyclohexenl -yl ketone v In the manner given in Example 31, 2-(p-hydroxybenzoyl)- cyclohexanone was reacted with octamethyleneimine in the presence of p-toluenesulfonic acid to give p-hydroxyphenyl 2- yl ketone; 3,5diiodophenyl 2-( 3-methylpiperidino)- I cyclohexen- 1 -y] ketone; 2-methoxy-4-chlorophenyl 2- piperidinol -cyclohexenl-yl ketone; 2-methyl-4- trifluoromethylphenyl 2-piperidinol-cyclohexen-1-yl ketone; 3,4-dipropylphenyl 2-pyrrolidino-l-cyclohepten-l-yl ketone; 2 ,5 -dichlorophenyl 2-(hexahydrol l-I-azepin- 1 -yl 1 cyclohepten-l-yl ketone; 3,4-dichlorophenyl 2-(3-methylpiperidino)-l-cycloocten-l-yl ketone; p-propoxyphenyl 2-(4- butylpiperazino)-l-cycloocten-l-yl ketone; 2,5-diiodophenyl 2-( 2-methylhexamethyleneimino)- l -cycloheptenl -yl ketone; 3-fluorophenyl 2-pyrrolidino-l-cyclopenten-l-yl ketone; 2- hexylphenyl 2-piperidino-l-cyclopenten-l-yl ketone; 3-pen- 30 tylphenyl Z-piperidino- 1 -cyclohexenl -yl ketone; 2-butylphenyl 2-morpholinol -cyclohexen- 1 -y] ketone; 2-
propylphenyl 2-( l,2,3,4-tetrahydro-l-quinolyl)-1-cyclohepten- 1 -yl ketone; 3-ethylpheny1 Z-pipen'dinol -cycloocten- 1 -yl ketone; 2-methoxy-5-bromophenyl 2-pyrrolidino-l-cyclopenten- 1 -y1 ketone; phenyl 2-octamethyleneiminol -cycloocten-l -yl ketone; phenyl 2-(2,3,6-trimethylmorpholino)-l-cyclohepten- 1 -yl ketone; and the like.
EXAMPLE 74 a-(p-Ethoxyphenyl)-2 hydrochloride In the manner given in Example 32, p-ethoxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-ethoxyphenyD-Z- piperidinocyclohexanemethanol recovered as hydrochloride;
-piperidinocyclohexanemethanol melting point 22 l -222 C.
EXAMPLE 75 a-(p-Benzyloxyphenyl)-2-pyrrolidinocyclohexanemethanol In the manner given in Example 32, p-benzyloxyphenyl 2- pyrrolidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-benzyloXyphenyl)-2- pyrrolidinocyclohexanemethanol.
EXAMPLE 76 Cis-A-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol In the manner given in Example 32, p-benzyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give cis-A-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol of melting point 148.5-149.5 C.
In the same manner, catalytic hydrogenation of cisbenzyloxyphenyl 2-piperidinocyclohexyl ketone (Example 88) gives the same product.
EXAMPLE 76A Cis-B-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol and hydrochloride thereof In the manner given in Example 47, cis-A-a-(p-benzyloxyphenyl)-2 piperidinocyclohexanemethanol was converted by means of trifluoroacetic acid to cis-B-a-(p-benzyloxyphenyl)- 2-piperidinocyclohexanemethanol of melting point 129130 C.
This base was treated with ethereal hydrogen chloride, to obtain cis-B-a-(p-benzyloxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride of melting point 238-240 C.
EXAMPLE 77 a-[ p-( 2-l-lydroxyethoxy)phenyl]-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, p-(2-hydroxyethoxy)- phenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-[p- (2-hydroxyethoxy)-phenyl]-2-piperidinocyclohexanemethanol recovered as hydrochloride of melting point 196198 C.
The hydrochloride can be converted to the free base, and the latter can be reacted with trichloroacetic acid to give the corresponding trichloroacetic acid salt, useful as a herbicide, for example, against Johnson grass, yellow foxtail, green foxtail, Bennuda grass and quack grass.
EXAMPLE 78 a-(o-Methoxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, o-methoxyphenyl 2- piperidino-l-cyclohexen-l-y1 ketone was hydrogenated in the presence of platinum oxide to give a-(o-methoxypheny1)-2- piperidinocyclohexanemethanol recovered as hydrochloride.
EXAMPLE 79 a-(o-Hydroxyphenyl)-2-piperidinocyclohexanemethanol In the manner given in Example 32, o-hydroxyphenyl 2- piperidinol-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(o-hydroxyphenyl)-2- piperidinocyclohexanemethanol of melting point l22-122.5 C.
The above compound is useful as a diuretic.
EXAMPLE 79A EXAMPLE 79B Cis-B-a-(p-hydroxyphenyl)-2-piperidinocycl0hexanemethanol In the manner given in Example 47, cis-A-a-(p-hydroxyphenyl)-2-piperidinocyclohexanemethanol was converted by means of trifluoroacetic acid to cis-B-a-(p-hydroxyphenyl)-2- cyclohexanemethanol of melting point l82l 83 C.
The above compound is useful as a diuretic.
EXAMPLE 8O a-(2-Methoxy-4-methylphenyl)-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, 2-methoxy-4- methylphenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(2- methoxy-4-methylphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride; melting point 25 l252 C.
EXAMPLE 81 a-( 3 ,5-Dimethyl-4-methoxyphenyl )-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, 3,5-dimethyl-4-methoxyphenyl 2-piperidin0-1-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a- (3,5-dimethyl-4-meth0xyphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride.
EXAMPLE 82 a-( p-Trifl uoromethylphenyl )-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, p-trifluoromethylphenyl Z-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(ptrifluoromethylphenyl)-2-piperidinocyclohexanemethanol recovered as hydrochloride.
EXAMPLE 83 a-(p-Propoxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, p-allyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-(p-propoxyphenyl)-2- piperidinocyclohexanemethanol recovered as hydrochloride.
EXAMPLE 83A Cis-A-a-(p-allyloxyphenyl)-2piperidinocyclohexanemet hanol A mixture of 11.6 g. (0.04 mole) of cis-A-a-(p-hydroxyphenyl)-2-piperidinocyclohexanemethanol and 1.8 g. of a 53.3 percent mineral oil dispersion of sodium hydride (0.04 mole of sodium hydride) in 100 ml. of dimethyl sulfoxide was stirred for a period of 1 hour. A solution of 4.9 g. (0.0404 mole) of allyl bromide in 15 ml. of ether was added to the mixture above during a period of 15 minutes and the obtained reaction mixture was stirred for 3 hours at room temperature and then poured in l l. of ice water. A white solid separated which was extracted three times with ether. The ether extracts were combined, washed with water and saturated sodium chloride solution, dried over anhydrous sodium sulfate and evaporated to give a residue. This residue was twice recrystallized from ether-pentane to give a total of l 1.8 g. (89 percent) of cis-A-a-(p-allyloxyphenyl)-2-piperidinocyclohexanemethanol of melting point 70-72 C.
Analysis:
Calcd. for C I-I NO Found: 9.10 N, 4.20
The above compound is useful as an oral antidiabetic agent.
EXAMPLE 84 a-[p-(Methylcarbamoyloxy)phenyll-2-piperidinocyclohexanemethanol hydrochloride In the manner given in Example 32, p-(methylcarbamoyloxy)-phenyl 2-piperidino-l-cyclohexen-l-yl ketone was hydrogenated in the presence of platinum oxide to give a-[p- (methylcarbamoyloxy)-phenyl]-2-piperidinocyclohexanemethanol recovered as hydrochloride.
EXAMPLE 85 EXAMPLE 86 a-( p-Chlorophenyl )-2-( 2-isopropylpyrrolidino )cyclohexanemethanol hydrochloride In the manner given in Example 32, p-chlorophenyl 2-(2- isopropy1pyrrolidino)-l-cyclohexen-1-yl ketone was hydrogenated in the presence of platinum oxide to give oz-(pchlorophenyl)-2-(2-isopropylpyrrolidino)cyclohexanemet hanol recovered as hydrochloride.
EXAMPLE 87 a-(p-I-Iydroxyphenyl)-2-octamethyleneiminocyclohexanemethanol hydrochloride In the manner given in Example 32, p-hydroxyphenyl 2-0ctamethyleneiminol -cyclohexenl -yl ketone was hydrogenated in the presence of platinum oxide to give a-(phydroxyphenyl)-2-octamethyleneiminocyclohexanemethanol recovered as hydrochloride.
In the same manner given in Example 32, hydrogenating other keto compounds of formula II in the presence of platinum oxide gives the substituted methanols of the formula IV recovered as hydrochlorides. Representative hydrochlorides, thus obtained, include: the hydrochlorides of a-(o-methylphenyl)-2-pyrrolidinocyclohexanemethanol; a- (p-methylphenyl)-2-pyrrolidinocyclohexanemethanol; a-(2- methoxy-4-methylphenyl)- 2-morpholinocyclohexanemethanol; a-(2-hydroxy-5-chlorophenyl)-2- homomorpholinocyclohexanemethanol; a-[p-(carboxymethoxy)phenyl]-2-(3,6-dimethylhexamethyleneimino)cyclohexanemethanol; a-( 3,4- methylenedioxyphenyl)-2-(Z-methylpiperidino)cyclohexanemethanol; a-(p-ethoxyphenyl)-2-pyrrolidinocycloheptanemethanol; a-( 2,3 ,4-trimethoxyphenyl )-2-piperidinocyclooctanemethanol; a-( 3 ,5 -diiodophenyl)-2-( 3-methylpiperidino)cyclohexanemethanol; a-( 2- methoxy-4- chlorphenyl )-2-piperidinocyclohexanemethanol; a-( 2- methyl-4-trifluoromethylphenyl )-2-piperidinocyclohexanemethanol; a-(3,4-dipropylphenyl)-2-pyrrolidinocyc1oheptanemethanol; a-(2,5-dichlorophenyl)-2-(hexahydro-1H- azepinl -yl )cycloheptanemethanol; a-( 3 ,4-dichlorophenyl)-2 3-methylpiperidino )cyclooctanemethanol; a-( p-propoxyphenyl)-2-(4-butylpiperazino)cyclooctanemethanol; (Jr-(2,5- diiodophenyl)-2-( Z-methylhexaniethylneimino)cyclohepta nemethanol; a-( 3-fluorophenyl)-2-pyrrolidinocyclopentanemethanol; a-( 2-hexylphenyl)-2-piperidinocyclopentanemethanol; a-( 3-penty1phenyl )-2-piperidinocyclohexanemethanol; a-( Z-butylphenyl )-2-morpholinocyclohexanemethanol; a-( 2-propylphenyl)-2-( l,2,3,4-tetrahydro-lquinolyl)cycloheptanemethanol; a-(3-ethylphenyl)- 2- piperidinocyclooctanemethanol; a-(2-methoxy-5- bromophenyl)-2-pyrrolidinocyclopentanemethanol; a-pheny1-2 -octamethyleneim'inocyclooctanemethanol; a-phenyl-Z- (2,3,6-trimethylmorpholino)cycloheptanemethanol; and the like.
EXAMPLE 88 Cis-p-benzyloxyphenyl Z-piperidinocyclohexyl ketone In the manner given in Example 39, p-benzyloxyphenyl 2- piperidino-l-cyclohexen-l-yl ketone dissolved in ethanol was hydrogenated in the presence of platinum oxide until one molar equivalent of hydrogen was consumed (42 minutes) to give cis-p-benzyloxyphenyl Z-piperidinocyclohexyl ketone of melting point 87.588.5 C.
Analysis:
Calcd. for C H NO C, 79.53; H, 8.28; N, 3.71 Found: C, 78.88; H, 8.27; N, 3.65
In the same manner given in Example 39, selective catalytic reduction (preferably with platinum oxide) of other compounds of formula II produces cis-ketones of formula III, e.g., cis-3,4,5-trimethoxyphenyl 2-piperidinocyclohexyl ketone; cis-p-ethoxyphenyl Z-piperidinocyclohexyl ketone; cis-p-(2- hydroxyethoxy)-phenyl 2-piperidinocyclohexyl ketone; cis-ptrifluoromethylphenyl Z-piperidinocyclohexyl ketone; cis-pchlorophenyl 2-(2-isopropylpyrrolidino)cyclohexyl ketone; cis-3 ,4-methylenedioxyphenyl 2-( hexahydrol I-I-azepinl ketone; cis-2,3,4-trimethoxyphenyl 2- piperidinocyclooctyl ketone; cis-3,4 -dichlrophenyl 2-(3- methylpiperidino)cyclooctyl ketone; cis-2,5-dichlorophenyl 2-(hexahydro-1l-I-azepinyl-l-yl)cycloheptyl ketone; and the like.
In the manner given in Example 41, other cis-alcohols can be obtained by hydrogenating a compound of formula II or III in the presence of a catalyst such as platinum oxide, palladium or the like. Representative compounds thus obtained include: cis-a-(p-methylphenyl)-2-piperidinocyclohexanemethanol, melting point l02-l03 C., as hydrochloride melting point 25 l25 3 C.; cis-a-( p-methoxyphenyl )-2-( 4-methyll piperazinyl)cyclohexanemethanol, melting point 132133 C.; cis-a-( p-methoxyphenyl)-2-( 4-methylpiperidino)cyclohexanemethanol, melting point 93-94 C.; cis-a-(p-methoxyphenyl)-2-morpholinocyclohexanemethanol, melting point 1ll-112 C.; cis-a-(p-methoxyphenyl)-2-( 3-azabicyclo[ 3 ,2,2 ]nonan-3-yl )cyclohexanemethanol, melting point 114.5115.5 C.; cis-a (pmethoxyphenyl)-2-pyrrolidinocyclohexanemethanol, melting point l46-l47 C.; cis-a-(p-methoxyphenyl)-2-(2-methylpiperidino)cyclohexanemethanol, as perchlorate, melting point l081 1 1 C.; cisa-(p-methoxyphenyl)-3,3-dimethyl-6- piperidinocyclohexanemethanol, melting point l33l35 C.; cis-a-(4-methoxy-3,S-dimethylphenyl)-2-(hexahydro-1H- azepin-l-yl)cyclohexanemethanol, as hydrochloride, melting point 247248 C.; cis a-(2,4-dimethylphenyl)-2-piperidinocyclohexanemethanol, as hydrochloride, melting point 34 239-240 C.; cis-a-( 2,5-dichlorophenyl )-2-heptamethyleneiminocycloheptanemethanol; cis-a-( Z-butylphenyl)-2-morpholinocyclohexanemethanol; cis-a-(Z-propylphenyl)-2-( 1,2,3 ,4-tetrahydro- 1 -q uinolyl)cycloheptanemethanol; cisa (2,3,4 trimethoxyphenyl) Z-piperidinocyclooctanemethanol; and the like.
EXAMPLE 89 1-[2-(a,3,4,5-Tetramethoxybenzyl)cyclohexyl]piperidine hydrochloride (isomer cis-A hydrochloride) A solution of 4 g. (0.01 mole) of a-(3,4,5-trimethoxyphenyl)-2-piperidinocyclohexanemethanol hydrochloride in 160 ml. of water was basified by adding sufficient 10 percent aqueous sodium hydroxide solution. This solution was extracted three times with 100 ml. of methylene chloride. The methylene chloride solution was evaporated, leaving an oily free base.
A solution of the free base a-(3,4,5-trimethoxyphenyl)-2- piperidinocyclohexanemethanol in 25 ml. of ether was added to 100 ml. of liquid ammonia containing 0.01 mole of sodium amide and the mixture was stirred for a period of 50 minutes, while cooling in Dry Ice-acetone. A solution of 1.42 g. (0.01 mole) of methyl iodide in 5 ml. of ether was then added during 5 minutes; the Dry Ice bath was removed and the mixture allowed to stir at room temperature for a period of 7 hours. It was then allowed to evaporated overnight (about 20 hours). To this reaction mixture was then added 50 ml. of water, and the mixture was extracted with three portions of 50 ml. each of methylene chloride. The combined methylene chloride extracts were washed with water, saturated salt solution, dried by passing through anhydrous sodium sulfate and evaporated, to give 3.6 g. of an oily product. The oil was dissolved in methylene chloride and chromatographed on 108 g. of Florisil (anhydrous magnesium silicate). The column of Florisil was eluted with four portions, each 200 ml., of a 3 percent acetone-97 percent Skellysolve B hexanes solution, yielding 1.80 g. of an oil after evaporation of the solvents. The oil was dissolved in ether and treated with ethereal hydrogen chloride to give 1.4 g. of material melting at 227-228 C. This material was recrystallized from methanol-ether to give 1-[2-(a,3,4,5- tetramethoxybenzyl)cyclohexyl]hpiperidine hydrochloride (isomer cis-A hydrochloride) of melting point 224-225 C. Ultraviolet: A max. 212 (33,400); sh 235 (6,600); 271 (923); sh 279 (646).
Analysis:
calcd. for e igma-H01:
C, 63.82; H, 8.77; CI, 8.56;
Found: C, 63.70; H, 8.95; Cl, 8.25; N
Cis-B-l-[2-(a,p-dimethoxybenzyl)cyclohexyl]piperidine and hydrochloride thereof A. A solution of cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol (3.0 g.; 0.01 mole) in 50 ml. of methanol was treated with a solution of 5 g. of hydrogen chloride in 50 ml. of methanol, and an additional 100 ml. of methanol was added. The solution was allowed to stand for 18 hours at about 25 C. and was then evaporated to dryness of 45 C. under reduced pressure. The oily residue was dissolved in 50 ml. of water; the solution was basified with aqueous sodium hydroxide solution and extracted with ether. The extract was washed with water, then with saturated sodium chloride solution, dried through anhydrous sodium sulfate, and evaporated to dryness, to obtain 3.0 g. percent yield) of cis-B- l 2-( a,p-dimethoxybenzyl)cyclohexyl]piperidine of melting point 7577 C. Recrystallization from ethanol gave 2.3 g. of this compound, melting point 8182 C. Ultraviolet: A max. 226 13,200); 275 (1,460); 282 (1,210).
Analysis:
Calcd. for C H NO C, 75.67; H, 9.84; N, 4.41 Found: C, 75.70; H, 10.06; N, 4.15
A solution of 10.7 g. (0.0354 mole) of cis-B-l-[2-(a,pdimethoxybenzyl)cyclohexyl]50 ml. of ether was treated with 40 ml. of 1.3 N ethereal hydrogen chloride solution. The resulting solid was crystallized from 25 ml. of methylene chloride and 50 ml. of ether to give 9.3 g. of cis-B- 1-[2-(a, p-dimethoxybenzyl)cyclohexyl]piperidine hydrochloride of melting point 20921 1 C. Ultraviolet: A max. 227 (12,500); 275 (1,400); 281 (1,200).
Analysis:
Calcd. for C H NO HClZ C, 67.87; H, 9.11;C 1 Found: C, 67.41; H, 9.31; C l,
B. In the manner given in Example 89, an ether solution of cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol was treated in liquid ammonia with sodium amide and methyl iodide. The cis-B-1-[2-(a,p-dimethoxybenzyl)cyclohexyl1piperidine thus obtained was identical with the compound prepared by the above methanolhydrogen chloride etherification procedure.
EXAMPLE 91 Cis-B-l-[2-(a,p-methoxybenzyl)cyclohexyl]piperidine N- oxide hydrate To an lee-cooled solution of 2.2 g. (7 mmoles) of cis-B-1-[2 -(a,p-dimethoxybenzyl)cyclohexyl]piperidine in 50 ml. of methanol was added 2.4 g. (14 mmoles) of m-chloroperbenzoic acid. The resulting colorless solution was allowed to stand in ice for 6 hours and then at room temperature (23 to 25 C.) for about 18 hours. It was evaporated to dryness at 35 C. to give an oily residue. To this residue was added 25 ml. of water followed by 25 ml. of percent aqueous sodium hydroxide, and then the mixture was extracted three times with a total of 100 ml. of methylene chloride. The methylene chloride extracts were combined, washed twice with saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated to give 2.5 g. of an oil. The oil was dissolved in 25 ml. of hot ethyl acetate (saturated with water), and the cloudy solution was filtered through a sinter funnel. The resulting clear solution was evaporated to ml., cooled and seeded. The resulting crystals were recovered by filtration and washed with ether to give colorless prisms of cis-B-l-[2-(a,pdimethoxybenzyl)cyclohexyl]melting at l08-1 10 C.
Ultraviolet: A max. 227 (12,750); 275 (1,400); 282 (1,250).
N, 3. C, 68.66; H, 9. N, 3.
99 Found: 96
EXAMPLE 92 Cis-B- l -[2-(a,p-dimethoxybenzyl )cyclohexyl]piperidine and its methiodide A solution of 4 ml. of butyl lithium (0.01 mole) in hexane was added during 2 minutes to a solution of 3.03 g. (0.01 mole) of cis-B-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol in 30 ml. of purified tetrahydrofuran. The mixture was stirred at room temperature for 30 minutes and then cooled in a Dry Ice bath at -70 C. To this solution was added a solution of methyl iodide (1.42 g.; 0.01 mole) in 10 ml. of tetrahydrofuran, dropwise, over a period of 10 minutes. The mixture was stirred at 70 C. for a period of 1.5 hours and then at room temperature for 19 hours. To the solution was thereupon added water (50 ml.) and the solution was then extracted with three portions of 75 ml. each of methylene chloride. The organic extracts were combined, dried by passage through anhydrous sodium sulfate and evaporated to give 2.7 g. of crude product. The crude product was dissolved in 20 ml. of methylene chloride and chromatographed over 135 g. of neutral alumina. The material was first eluted with eight portions of 250 ml. of a 5 percent ether-95 percent Skellysolve B hexanes solution. After evaporation of the combined eluates, 1.523 g. of solid material, melting between 82-84 C., was obtained. Further elution with two portions of 250 ml. of 25 percent ether-75 percent Skellysolve B hexanes, with two portions of 250 ml. each of 50 percent ether-50 percent Skellysolve B hexanes and with two portions of 250 ml. each of 75 percent ether-25 percent Skellysolve B hexanes gave a total of 0.204 g. of solid material after evaporation of the combined eluates. The above fractions were all combined and recrystallized from ethanol to give 0.644 g. of cis-B-l-[2-(a,pdimethoxybenzyl)cyclohexy|]84-85.5 C. This free base was identical with the free base obtained in Example 90, parts A and B.
Further elution of the column with 250 ml. of methanol gave 1.446 g. of material which was crystallized from methanol-ether overnight in the refrigerator to give 0.252 g. of the methiodide of cis-B-1-[2-(a,p-dimethoxybenzyl)cyclohexyl]piperidine, melting after another recrystallization from methanol-ether at 217218 C.
Ultraviolet: A max. 223 (24,000); 275 (1,390); 281 (1,280).
Analysis:
Calcd. for C H INO C, 54.90; H, 7.46; I, 27.63; Found: C, 55.03; H, 7.68; l, 27.63;
EXAMPLE 92A Analysis:
Calcd. for C H ,NO -CH OH-HCl:
C, 65.34; H, 9.40; Cl, 9.19; Found: C, 65.50; H, 9.28; Cl, 8.50;
EXAMPLE 93 Trans-C-l-[2-(a,p-dimethoxybenzyl)cyclohexyl] piperidine A solution of butyl lithium in hexane (5.25 ml., containing 0.01 mole) was added during a period of 10 minutes to a solution of a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol (3.03 g.; 0.01 mole of the trans-C alcohol) in 40 ml. of tetrahydrofuran in a nitrogen atmosphere. The reaction mixture was then stirred for 45 minutes. It was cooled to C. and thereto was added a solution of 1.41 g. (0.01 mole) of methyl iodide in 10 ml. of purified tetrahydrofuran over a period of 30 minutes. The mixture was then stirred at room temperature (about 25 C.) overnight for about 16 hours. The reaction mixture was thereupon evaporated to dryness and the resulting residue was dissolved in 50 ml. of water and 50 ml. of methylene chloride. The aqueous layer was extracted with methylene chloride and the methylene chloride extracts combined, washed with saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated, to give 3.2
Analysis:
Calcd. for C d-1 ,190,:
C N, 4.4 l N, 4.7 1
75.67; H, 9.84; Found: C, 75.80;1-1, 10.08;
The same product was obtained. when trans-C-a-(p-methoxy-phenyl)-2-piperidinocyclohexanemethanol in methanol solution was treated with anhydrous hydrogen chloride in methanol solution and the resulting hydrochloride was treated with 20 percent aqueous sodium hydroxide.
, EXAMPLE 94 Trans-D- 1 2-(a,p-dimethoxybenzyl)cyclohexyl1piperidine A hexane solution of butyl lithium 5.25 ml.; 0.01 mole) was added during minutes to a solution of trans-D-a-(p- 'methoxyphenyl)-2piperidinocyclohexanemethanol (3.03 g.;
0.01 mole) in 30 ml. of purified tetrahydrofuran in a nitrogen atmosphere. The mixture was stirred for a period of 40 minutes, then cooled to 70 C. and a solution of 1.42 (0.01 mole) of methyl iodide in 10 ml. of purified tetrahydrofuran was added over a period of 30 minutes. The mixture was then stirred for 18 hours at room temperature, evaporated to dryness and the residue dissolved in 50 ml. of water and 50 ml. of methylene chloride. The aqueous layer was extracted with methylene chloride and thecombined methylene chloride extracts were washed withsaturated salt solution, dried through sodium sulfate and evaporated. The crude product, amounting to 3.2 g., was chromatographed over 100 g. of neutral alumina using five fractions of 150 ml. each of 6 percent ether-94 percent Skellysolve B hexanes. The five fractions were combined and evaporated to give 1.145 g. of oily trans-D-l-[2-(a,p-
dimethoxybenzyl)cyclohexyl]Ultraviolet: A max. 228 (12,-
Analysis:
Calcd. for C H NO C, 75.67; H. 9.84; N, 4.41 Found: C, 75. 8; H, 9.93; N, 4.30
EXAMPLE 95 Trans-C- l 2-( a,p-dimethoxybenzyl)cyclohexyl1piperidine A solution of 2 g. of hydrogen chloride in ml. of methanol was added to a solution of 0.8 g. (2.64 moles) of a- (p-methoxyphenyl )-2-piperidinocyclohexanemethanol (trans- D isomer) in 40 ml. of methanol. The mixture was allowed to stand overnight. The resulting solution was basified with percent aqueous sodium hydroxide solution. The methanol was evaporated in vacuo, ml. of water was added, and the product was extracted with three portions of 25 ml. each of methylene chloride. The extracts were combined, washed with saturated salt solution, dried over magnesium sulfate and evaporated. The residue (0.08 g.) was dissolved in 3 percent ether-97 percent Skellysolve B hexanes and chromatographed over neutral alumina with the same solvent mixture. The column was eluted with ten portionsof ml. each of 3 percent ether-97 percent Skellysolve B hexanes and the fractions thus obtained were evaporated to give 0.351 g. of an oil, which was kept overnight at --l0 C. and thereupon solidified. The solidified material was crystallized from methanol to give trans-C-1-[2-(a,p-dimethoxybenzyl)cyclohexyl]piperidine of melting point 78-79 C., identical with the compound of Example 93.
EXAMPLE 96 1-[ 2-( a-Ethoxy-p-methoxybenzyl)cyclohexyl]piperidine (cis-A isomer) and the hydrochloride thereof A solution of cis-A-a-(p-methoxyphenyl)-2-piperidinocyclohexanemethanol (30.3 g.; 0.1 mole) in 250 ml. of ether was added during 45 minutes to a suspension of freshly prepared sodium amide (0.2 mole) in l l. of liquid ammonia. The mixture was stirred for 1 hour and then cooled in a Dry Ice-acetone bath. A solution of 31.2 g. (0.2 mole) of ethyl iodide in 100 ml. of ether was added dropwise over a period of 30 minutes, the mixture was then stirred'in the cold for 1 hour and allowed to stir without cooling for 2 hours. The solution was thereupon allowed to evaporate overnight. To the resulting product 500 ml. of water was added, and the mixture was extracted with 5 portions of 100 ml. each of methylene chloride. The extracts were combined, washed with water, then with saturated salt solution, dried by passage through anhydrous sodium sulfate and evaporated to give 30 g. of a yellow oil. A solution of this oil in 200 ml. of petroleum ether (boiling range 3060 C.) was allowed to crystallize overnight to give 15.8 g. (53 percent recovery) of starting alcohol as determined by mixed melting point (78-80 C.). The filtrate was evaporated, and the residue was chromatographed over 750 g. of neutral alumina. Elution with 6 percent ether-94 percent Skellysolve B hexanes (8 fractions 250 ml. each) gave 7.23 g. of oily cis-A-1-[2-(a-ethyoxy-p-methoxybenzyl)cyclohexyl]piperidine which was 98.9 percent pure as determined by vapor phase chromatography. Further elution with 25 percent ether-75 percent Skellysolve B hexanes (4 fractions of 250 ml. each) gave 0.546 g. of oil of one component; 50 percent ether-50 percent Skellysolve B hexanes (4 fractions 250 ml. each) gave 0.777 g. of oil and 2 fractions of 450 ml. each gave 0.396 g. of oil. Total yield from the ethyl ether fractions were 30 percent. This 011 did not crystallize. The oily cis-A-1-[2-(asethoxy-p-methoxybenzyl)cyclohexyl] piperidine had the following analysis: Ultraviolet: A max. 226.5 (12,000); sh 268, 276 (1,800); 284 (1,550).
Analysis:
Calcd. for C l-1 190,:
Found The hydrochloride of cis-A-l-[2-(a-ethoxy-p-methoxybenzyl)-cyclohexyl]piperidine was prepared by treatment of an ethereal solution of the above oily base with ethereal hydrogen chloride. Two recrystallizations from ethanol gave colorless prisms of the hydrochloride of cis-A-l-[2-(a-ethoxy' p-methoxybenzyl)cyclohexy11piperidine of melting point 203-204.5 C.
Ultraviolet: A max. 227 1 1,900); 275 (1,500); 282 (1,300).
Analysis:
Calcd. for C H NO -HCl:
C, 68.55; H, 9.31; Cl, 9.64; Found: C, 68.01; H, 9.42; Cl, 9.72;
EXAMPLE 97 1-[2-(a-Ethoxy-p-methoxybenzyl)cyclohexyllpiperidine (cis-B isomer)
Claims (9)
- 2. The substituted methanol hydrochloride of claim 1, wherein n is 2, R'', R'''' and R'''''' are 3-, 4-, and 5- methoxy groups, which has a melting point of about 244*-246* C., and is therefore Alpha -(3,4,5-trimethoxyphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol hydrochloride.
- 3. The substituted methanol hydrochloride of claim 1, wherein n is 2, R'' and R'''' are hydrogen, R'''''' is p-methoxy, which has a melting point of about 230*-231* C. and is therefore cis-A- Alpha -(p-methoxyphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol hydrochloride.
- 4. The substituted methanol hydrochloride of claim 1, wherein n is 2, R'' and R'''' are hydrogen and R'''''' is p-trifluoromethyl, which has a melting point of about 263*-264* C. and is therefore Alpha -(p-trifluoromethylphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol hydrochloride.
- 5. The substituted methanol hydrochloride of claim 1, wherein n is 2, R, and R'''' are hydrogen, R'''''' is p-chloro, which has a melting point of about 274*-275* C. and is therefore Alpha -(p-chlorophenyl)-2-(hexahydro-1H-azepin-1-yl)-cyclohexanemethanol hydrochloride.
- 6. The substituted methanol hydrochloride of claim 1, wherein n is 2, R,, R'''', and R'''''' are hydrogen, which has a melting point of about 276*-277* C. and is therefore Alpha -phenyl-2-(hexahydro-1H-azepin-1-yl)cycloHexanemethanol hydrochloride.
- 7. The substituted methanol hydrochloride according to claim 1, wherein n is 2, R, and R'''' are 3- and 4-methoxy and R'''''' is hydrogen, which has a melting point of about 225*-226* C. and is therefore Alpha -(3,4-dimethoxyphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol hydrochloride.
- 8. The substituted methanol compound according to claim 1, wherein n is 2, R'', and R'''' are hydrogen and R'''''' is p-methoxy, which has a melting point of about 94*-95.5* C. and is therefore cis-B- Alpha (p-methoxyphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol.
- 9. A substituted methanol quaternary ammonium halide salt according to claim 1, which is Alpha -(3,4,5-trimethoxyphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol methiodide of melting point about 191*-193* C.
- 10. The substituted methanol hydrochloride compound according to claim 1, wherein n is 2, R'', is 4-methoxy and R'''' and R'''''' are 3-and 4-methyl groups, which has a melting point of about 247*-248* C. and is therefore cis- Alpha -(4-methoxy-3,5-dimethylphenyl)-2-(hexahydro-1H-azepin-1-yl)cyclohexanemethanol hydrochloride.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55689266A | 1966-06-13 | 1966-06-13 | |
| US8571870A | 1970-10-30 | 1970-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3668199A true US3668199A (en) | 1972-06-06 |
Family
ID=26773015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US85718A Expired - Lifetime US3668199A (en) | 1966-06-13 | 1970-10-30 | 1,3-aminoalcohols |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3668199A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2508445A1 (en) * | 1981-06-29 | 1982-12-31 | Sori Soc Rech Ind | NOVEL BENZOYL-PHENYL-PIPERIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE, IN PARTICULAR THERAPEUTICS |
| US4540690A (en) * | 1982-02-09 | 1985-09-10 | The Upjohn Company | 2-(Phenylmethylene)cycloalkylamines and -azetidines |
| US4652559A (en) * | 1982-08-16 | 1987-03-24 | The Upjohn Company | 2-(Phenylmethylene)cycloalkyl-azetidines |
| US5916786A (en) * | 1997-12-19 | 1999-06-29 | Biocatalytics, Inc. | Method for the production of chiral 1,3-aminoalcohols |
| WO1999032649A1 (en) * | 1997-12-19 | 1999-07-01 | Biocatalytics, Inc. | Methods and precursors for the production of chiral 1,3-aminoalcohols |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3257413A (en) * | 1963-06-24 | 1966-06-21 | Abbott Lab | Tricarbocyclic derivatives of p-aminoalkoxybenzhydrol |
-
1970
- 1970-10-30 US US85718A patent/US3668199A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3257413A (en) * | 1963-06-24 | 1966-06-21 | Abbott Lab | Tricarbocyclic derivatives of p-aminoalkoxybenzhydrol |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2508445A1 (en) * | 1981-06-29 | 1982-12-31 | Sori Soc Rech Ind | NOVEL BENZOYL-PHENYL-PIPERIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE, IN PARTICULAR THERAPEUTICS |
| EP0069012A1 (en) * | 1981-06-29 | 1983-01-05 | Societe De Recherches Industrielles S.O.R.I. | Benzoyl-phenyl-piperidine derivatives, their preparation and medicinal use |
| US4528294A (en) * | 1981-06-29 | 1985-07-09 | Societe De Recherches Industrielle S.O.R.I. | Benzoyl-phenyl-piperidine derivatives |
| US4540690A (en) * | 1982-02-09 | 1985-09-10 | The Upjohn Company | 2-(Phenylmethylene)cycloalkylamines and -azetidines |
| US4652559A (en) * | 1982-08-16 | 1987-03-24 | The Upjohn Company | 2-(Phenylmethylene)cycloalkyl-azetidines |
| US5916786A (en) * | 1997-12-19 | 1999-06-29 | Biocatalytics, Inc. | Method for the production of chiral 1,3-aminoalcohols |
| WO1999032649A1 (en) * | 1997-12-19 | 1999-07-01 | Biocatalytics, Inc. | Methods and precursors for the production of chiral 1,3-aminoalcohols |
| US6207862B1 (en) | 1997-12-19 | 2001-03-27 | Biocatalytics, Inc. | Precursors for the production of chiral 1,3-aminoalcohols |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3293263A (en) | Diphenylbenzocycloalkenes | |
| US3274213A (en) | Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes | |
| JP2637737B2 (en) | New drugs | |
| US3396169A (en) | Substituted 2-phenyl-1-(tertiary-aminoalkoxy) phenyl-3, 4-dihydronaphthalenes | |
| US3821234A (en) | 1-pyrazoly-alkyl-4-phenyl-3,4-dehydropiperidines | |
| Biel et al. | Antispasmodics. I. Substituted Acetic Acid Esters of 1-Alkyl-3-hydroxypiperidine1 | |
| IL23338A (en) | N-phenylpiperazine compounds | |
| US4478750A (en) | 1-Phenyl-azepinoindoles | |
| US3678111A (en) | Dialkylaminomethylphenyl benzyl alcohols | |
| US3668199A (en) | 1,3-aminoalcohols | |
| US3164607A (en) | 2-phenyl-3-(tertiary amino alkoxy) phenyl-indenes | |
| US4021564A (en) | Neuroleptic piperidine compounds | |
| GB2058049A (en) | Production of methylene-cycloamines | |
| US3558599A (en) | 1-(2-(alpha-alkoxybenzyl and substituted benzyl)cycloalkyl)heterocyclic amines | |
| US3627763A (en) | Substituted 2-benzyl-benzofuran derivatives | |
| US3705176A (en) | 1,3-aminoalcohols | |
| US3595867A (en) | 2 - piperidino- and methyl-substituted piperidino-substituted-phentl cycloalkane-methanols and derivatives | |
| US3632813A (en) | Substituted phenyl 2-piperidinocycloalkyl ketones | |
| NZ187333A (en) | 2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles | |
| US4216326A (en) | Intermediates for preparing anti-inflammatory phenyl-lower-alkylamines | |
| US3468881A (en) | Allylic amines | |
| US3370058A (en) | 5-acyl morphanthridine derivatives | |
| US3598808A (en) | Perhydro-5-phenyl-cycloalkapolyene-1,4-oxazepines and their preparations | |
| US3499033A (en) | Ethers of alpha-phenyl-2-aminocycloalkanemethanols | |
| US3506670A (en) | 2-hetero-amino-alpha,alpha-diaryl-cycloalkone-methanols and esters thereof |